The Role of Microbiota in Infant Health: From Early Life to Adulthood

Abstract

From early life to adulthood, the microbiota play a crucial role in the health of the infant. The microbiota in early life are not only a key regulator of infant health but also associated with long-term health. Pregnancy to early life is the golden time for the establishment of the infant microbiota, which is affected by both environmental and genetic factors. Recently, there is an explosion of the studies on the role of microbiota in human diseases, but the application to disease or health is relatively limited because many aspects of human microbiota remain controversial, especially about the infant microbiota. Therefore, a critical and conclusive review is necessary to understand fully the relationship between the microbiota and the health of infant. In this article, we introduce in detail the role of microbiota in the infant from pregnancy to early life to long-term health. The main contents of this article include the relationship between the maternal microbiota and adverse pregnancy outcomes, the establishment of the neonatal microbiota during perinatal period and early life, the composition of the infant gut microbiota, the prediction of the microbiota for long-term health, and the future study directions of microbiota.

1 Introduction

The emergence of the concept of the microbiome and the development of molecular technology, especially 16S rRNA, have greatly increased the understanding of the microbiota in maternal-fetal interface and early life (Table 1 for glossary of terms). This makes it possible to characterize the microbiota of pregnant women and their offspring without culturing. During pregnancy, the maternal microbiota affects the development of the fetus, especially the brain development, such as the uterine microbiota, the vagina microbiota, the gastrointestinal microbiota, the placental microbiota (controversial), and the oral microbiota. Notably, the disorder of the maternal microbiota can lead to adverse pregnancy outcomes (APOs), which seriously threaten the health of the offspring. After birth, the infant microbiota affected by both environmental and genetic factors are quickly established to ensure healthy growth. In this article, we describe the role of the microbiota (including the maternal microbiota during pregnancy and the infant microbiota during early life) in the health of offspring from pregnancy to long-term health. These provide a theoretical basis for improving infant health by adjusting the microbiota in pregnancy and early life and promote the understanding of maternal and fetal health.

The search strategy of this article: We search literature and collect data through Web of Science and Pubmed. First, we use different keyword combinations to search, including infant or newborn or offspring, microbiota* or microbiome* or microbe*, maternal, pregnancy or pregnant or gestation*, etc. Secondly, we read the retrieved articles and eliminate irrelevant articles. Then, we read the rest of the literature carefully and developed a manuscript outline. Finally, we extract the target content from the literature through summary and induction.

2 The Maternal Microbiota and Offspring During Pregnancy

2.1 The Maternal Microbiota During Pregnancy

Previously, the culprit of intrauterine infections in the fetus was considered to be the microbes that rise from the vagina, such as bacteria, viruses, and fungi. However, with the development of science and technology, the oral and gut microbiota have been found to be also associated with the health of the fetus because the microbiota in these parts can spread through the blood. During pregnancy, the mother’s gut, oral cavity, and vagina microbiota all undergo changes. These changes are related to a variety of factors, including diet, antibiotic use, infections, stress, and host genes (Figure 1) (1–5). The study of Romero et al. revealed that the stability of the vaginal microbiota of healthy pregnant women is higher than that of healthy nonpregnant women and Lactobacillus species were the main component of the vaginal microbiota of healthy pregnant women (6). Traditionally, the uterus is considered to be sterile, but this concept was broken until recent years. The endometrium has its own microbiota, and the biomass of these microbiota is very low (7). Regrettably, the current understanding of the endometrium microbiota is limited, and its role in fetal development and pregnancy outcome still needs to be fully elucidated.

Figure 1

Emerging evidence indicated that the richness and homogeneity of the gut microbiota of pregnant women are not significantly different from those of normal women, but the distribution and composition are changed obviously (8). In addition, pregnant women with pregnancy complications have a reduced diversity of their gut microbiota, which is detrimental to the health of both the mother and the fetus. For example, gut microbial remodeling during pregnancy in rats with chronic hypertension is impaired (9). The abundance of short-chain fatty acid-producing Coprococcus in the gut microbiota of pregnant women with preeclampsia is decreased (10). In 2014, Aagaard et al. found that the human placental microbiota are mainly composed of nonpathogenic symbiotic microbiota, including Fusobacteria phyla, Firmicutes, Bacteroidetes, Tenericutes, and Proteobacteria (11). The human placental microbiota are similar to the oral microbiota and limited diversity compared with the gut microbiota (11, 12). However, on the contrary, another study showed that the human placenta does not have microbiota but there may be potential pathogens (13). Also, the study concluded there is no correlation between bacterial infection of the placenta and common adverse pregnancy outcomes (APOs) (13).

The imbalance of the maternal microbiota leads to a variety of complications during pregnancy, such as obesity, hypertension, and preeclampsia. Here, we mainly introduce the impact of the maternal microbiota on the fetus, so we will not elaborate on the complications of pregnancy. The differential change of the maternal microbiota during pregnancy is an important cause of APOs. In the following paragraphs, we introduce the factors that affect the maternal microbiota and the impact of the maternal microbiota on APOs.

2.2 The Factors Affecting Maternal Microbiota During Pregnancy

At present, the factors that have been clearly proven to affect the microbiota of the vagina and other parts of pregnant women are diet, antibiotic use, infection, and maternal stress. Factors that need to be further studied are immune status, age, and genetic background. In addition to these factors, complications during pregnancy are also important influencing factors. For example, the changes in the composition of the gut microbiota, oral microbiota, and vaginal microbiota in patients with gestational diabetes are obvious (14). Pregnancy is one of the important windows for regulating the microbiota, and the influencing factors of the maternal microbiota have always been highly concerned. Although the abundance of many kinds of microbes has been proved to change significantly during pregnancy, the function of the specific microbes and their interaction with the host still need to be studied in depth. A precise understanding of the factors that affect the maternal microbiota is helpful to formulate an individualized plan, which can promote better management of the health of the mother and fetus during pregnancy.

2.3 The Role of the Maternal Gut Microbiota on Prenatal Development

The maternal nutritional status, immunity, and metabolism have always been the focus and difficulty in the study of the maternal-fetal interface. Maternal vital substances reach the placenta through blood circulation, and then spread or transport into the fetus’s body (15). During the first two-thirds of pregnancy, the mother exhibits hyperappetite and fat accumulation, at this time the development of the fetus is very limited (16). The fetus develops rapidly during the last third of gestation, when the maternal metabolism increases (16). The maternal microbiota are an important regulator of the metabolism and immunity during pregnancy, among which the gut microbiota are the most prominent (17–19). The gut microbiota can digest carbohydrates in the gut to produce vitamins, amino acids, and short-chain fatty acids (SCFAs) (20). As we all know, vitamins and amino acids are essential for fetal development, and SCFAs are also closely related to immunity and metabolism (21). Although the immune response and metabolic regulation mechanisms of adults are different from those of fetuses, it is also meaningful to explore the role of the maternal microbiota products in fetal development. The synthesis of SCFAs increases during pregnancy, which is necessary for the differentiation of regulatory T cells in the thymus of the fetus. In 2020, a study revealed that the changes in the diet of pregnant mice affect the growth and development of the fetus through the gut microbes (22). Specifically, pregnant mice fed undernourished (UN) or high-fat diet had lower plasma folic acid concentrations compared with the control group, and the relative abundance of the three Lactobacilli taxa in the gut of pregnant mice on a high-fat diet was higher compared with the control group. UN-fed or high-fat diet pregnant mice exhibit metabolic dysfunction and the fetal growth restriction. Furthermore, several studies suggested that the specific microbes in the maternal intestine are necessary for fetal immune system and neurodevelopment (3, 23, 24). The studies pointed out that segmented filamentous bacteria (SFB, common commensal bacteria in the cecum and ileum of mice) in the maternal intestine is the determinant of maintaining the level of IL-17A (IL-17A is related to the maternal immune activation). Consistently, the lack of IL-17A protects the fetus from behavioral disorders and neurodevelopmental disorders.

In summary, we conclude that the maternal gut microbiota and its metabolites are closely associated with the prenatal development of the fetus. However, we did not introduce the role of the maternal vagina and other parts of the microbiota in prenatal development because the current evidence in these areas is limited.

2.4 The Maternal Microbiota and APOs

Complications during pregnancy and APOs are the two most closely related to the maternal microbiota. We have previously introduced the former (14); here, we continue to introduce the latter. Currently, the APOs associated with the maternal microbiota include late abortion (LA), preterm rupture of membranes (PROM), hyperemesis gravidarum (HG), premature delivery (PTD), intrauterine growth restriction, and stillbirth (25). Worldwide, PTD is the most important factor leading to neonatal death (26). Also, intrauterine infection accounts for about 25%–40% of PTD (27). However, the cause of PTD caused by the maternal microbiota has not yet been revealed. The direct sources of the maternal microbiota that can cause fetal infection include placenta, umbilical cord, amniotic fluid, and fetal membranes; indirect sources include the gastrointestinal tract, vagina, skin and mucous membranes.

2.4.1 The Uterine Microbiota and APOs

The serious consequence of the bacterial invasion of the amniotic cavity is neonatal death (26). The uterine microbiota are minute and important (28). Bacterial culture experiments indicated that positive bacterial culture in amniotic fluid is positively correlated with gestational age, and the microbial composition of the first and third trimesters is different (29). The microbial load in the amniotic cavity of pregnant women with premature rupture of membranes is related to the severity of the inflammatory reaction in the amniotic membrane (30). The frequency of the microbiota in the amniotic cavity of PTD women is 40%, and 29% of them have sterile intraamniotic inflammation (31). The level of proinflammatory cytokines in the amniotic fluid of women who give birth within 34 weeks of gestation is upregulated (the full-age gestation period is approximately 280 days), which links PTD to intraamniotic infection (32, 33). Further research revealed that there are uncultivated microbes that may induce inflammatory response in the amniotic fluid of PTD women. In addition, culture-independent techniques showed 46% of women with PTD have intrauterine infections (34). The development of detection technology has increased the detection rate of microbes in amniotic fluid, which promotes the understanding of the relationship between the uterine microbiota and APOs. Currently, the clinical significance of PCR-positive amniotic fluid seems to be consistent with that of positive cultures (35). However, the mechanism by which the uterine microbes cause APOs, especially PTD, is still unclear.

2.4.2 The Vaginal Microbiota and APOs

The vaginal microbiota change not only during the female menstrual cycle but also during the reproductive process (36). The vaginal microbiota are closely related to women’s health, especially APOs. Malnourished women have an increased inflammatory response to the vaginal microbiota, which would lead to spontaneous preterm delivery (sPTD) (37, 38). Lactobacillus is the dominant species in the vagina, and its level may affect the APOs of pregnant women. Pregnant women with the low level of Lactobacilli in the vagina exhibit an increased risk of sPTD and diversity of Mycoplasma and Gardnerella vaginalis (38–40). Consistent with this, women with term deliveries have high levels of Lactobacillus and low bacterial diversity in the vagina (41, 42). However, not all Lactobacillus species in vagina are beneficial for pregnancy outcomes. For example, Lactobacillus iners is a risk factor leading to sPTD, but Lactobacillus crispatus is protective against sPTD (41, 42). A study in which participants were mainly African Americans showed that the diversity and abundance of vaginal microbes in term delivery women are significantly higher than that in PTD women (42). Concretely, Bifidobacterium longum/Bifidobacterium breve, Lactobacillus gasseri/Lactobacillus johnsonii, Lactobacillus iners/Ralstonia solanacearum, and Lactobacillus crispatus/Lactobacillus acidophilus of the vaginal microbiota might be related to decreased risk of PTD, and the vaginal community state type not dominated by Lactobacillus might be related to increased risk of PTD (43). In addition, the increased risk of PROM is associated with aerobic vaginitis (p < 0.05) (44). Consistently, Naomi Juliana et al. found that in Nigerian pregnant women, bacterial vaginosis is not associated with miscarriage and intrauterine growth retardation, but is associated with PROM, PTD, and low birth weight (45).

2.4.3 The Gut Microbiota and APOs

Among the maternal microbiota, the differences in the gut microbiota are the most striking and influential. However, the studies on the relationship between gut microbiota and APOs are limited, and most of the studies focus on gut microbiota and pregnancy complications. It seems that the gut microbiota is difficult to link directly to APOs because the intestine and the fetus are far apart in human anatomy. In recent years, the colonization of gut microbes in the vagina has linked the maternal gut microbiota with APOs. The migration of Listeria monocytogenes from the intestine to the vagina, leading to maternal-fetal infection, is a good example (46). A Danish report revealed that Listeria monocytogenes in pregnancy pose a serious threat to the fetus, and the rate of miscarriage or stillbirth among mothers infected with Listeria monocytogenes is as high as 32% (46). In addition, pregnant women have multiple identical microbiota in their vaginas and rectum, and 68% of them have the same genotype (47). From here, we can see that to a large extent there is a corresponding relationship between the vaginal microbiota and the rectal microbiota. The above evidence supports the link between the gut microbiota and APOs through the vaginal microbiota. Therefore, the gut microbiota can be used as a reservoir for vaginal probiotics, and regulating the gut microbiota is an effective strategy for improving pregnant women’s APOs.

Numerous microbial metabolites and components in the intestine have a powerful ability to regulate inflammatory response and immunity, which provides another link between maternal gut microbiota and APOs (21). Evidence indicated that the relative abundance of Prevotellaceae_UCG_003, Prevotella_1, and Selenomonas_1 in feces of aborted women is significantly reduced, and the level of proinflammatory cytokines in serum is increased (48). The study further pointed out that the metabolites of the gut microbiota are meaningful for recurrent miscarriage (48). Besides, the decrease in the alpha diversity of the gut microbiota is closely associated with the occurrence of sPTD, which may be regulated by the metabolites of the gut microbiota (49).

2.4.4 The Placental Microbiota and APOs

The existence of the placental microbiota is controversial. Some scholars believe that the human placental microbiota is unique and similar to the composition of oral microbiota (11, 12). Sweeney et al. observed that Ureaplasma species are the most common microbes in the placenta, and their relative abundance is related to PTD and term delivery (50, 51). In contrast, a study of 76 term delivery does not support the presence of placental microbiota (52). The study pointed out that the occasionally observed microbes may be caused by pollution, which does not represent the presence of placental microbes. Coincidentally, Kuperman et al. found that the fetus in the womb is sterile through the study of 28 human placenta and six mouse placenta (53). They believe even if the placental microbiota are present, their biomass is extremely low and the impact on the fetus may be small. There is no proof which view is right at present. The studies of placental microbiota should be carefully designed, analyzed, and conducted in an unbiased manner.

2.4.5 The Oral Microbiota and APOs

There is a Chinese proverb called “disease comes from the mouth”, which reflects the importance of oral microbes in human health from the side. There are many kinds of microbes that promote potentially APOs in the oral cavity, such as Campylobacter rectus, Porphyromonas gingivalis, Fusobacterium nucleatum, and Filifactor alocis. The pathways of the oral microbiota causing APOs may be (54): (1) Blood-borne spread of the oral microbes. (2) The immune response of the host and/or fetus to the pathogen causes inflammatory mediators to enter bloodstream. (3) Sexual behavior leads to the exchange of the oral and vaginal microbes. Porphyromonas gingivalis, the culprit of periodontitis, is a common anaerobic bacteria in the oral cavity and associated with many kinds of APOs, including fetal growth restriction (55), spontaneous abortion (56), and PTD (57). The mechanisms of Porphyromonas gingivalis causing APOs may be as follows: (1) Porphyromonas gingivalis directly invades the maternal tissue or placenta at the maternal-fetal interface (58). (2) Porphyromonas gingivalis evades the killing of the immune system by suppressing the immune response in the maternal tissues (59, 60). (3) Porphyromonas gingivalis leads to increased inflammatory response in maternal and fetal tissues via regulating the immune response (61). (4) Porphyromonas gingivalis promotes the increase of acute-phase proteins in maternal and fetal tissues, such as alpha-fetoprotein and C-reactive protein (62). (5) Porphyromonas gingivalis promotes the invasion and colonization of other maternal microbes. Therefore, the infection of Porphyromonas gingivalis could cause a systemic reaction to result in APOs, which is extremely detrimental to the health of the mother and fetus. It is very important for pregnant women to have good oral hygiene by controlling the oral microbiota.

3 The Microbiota and Offspring During Perinatal Period and Early Life

From birth to adulthood, environmental factors interact with genetic factors to maintain the healthy growth of the individual. During perinatal period and early life, the microbiota of offspring is closely related to the maternal microbiota, especially the neonatal and infant gut microbiota. Perinatal period and early life are the prime time for the colonization of the gut microbiota of offspring. The mode of delivery and gestational age at birth are important factors affecting the neonatal gut microbiota during the perinatal period. In early life, the determinants of the infant gut microbiota include feeding mode, maternal diet, environmental factors, and host genotype. In the following section, we introduce the establishment and development of neonatal gut microbiota and the driving forces of neonatal and infant gut microbiota.

3.1 Establishment and Development of Neonatal Microbiota

The establishment of neonatal gut microbes is the result of the interaction of environmental and host factors. Both beneficial and harmful microbes would colonize the neonatal intestines at birth and are profound for the health of infant (63) (Figure 2). The microbes that newborns are exposed to at birth are very important, especially the maternal microbes (64). Bacteria from the maternal vagina and skin have been observed in the feces of newborns (65). The mouth, skin, and intestines of newborns delivered vaginally are rich in Lactobacillus which is the core of the maternal vaginal microbiota (66). After birth, newborns would continue to obtain microbes from the maternal microbiota in different parts. Also, the colonization of these microbes is durable and stable.

Figure 2

The infant gut microbiota exhibits initially low diversity and then increases with early development. In early life, the microbes that colonize the intestine are usually aerobic bacteria because the intestine is aerobic. After adulthood, the microbes colonized in early life will be replaced by typical anaerobic bacteria in the intestine (67). Studies on the gut microbiota of infants indicated that Clostridia, Enterobacteria, and Streptococci were observed in the infant intestines in the first 2 days after birth (68). Clostridia, Bacteroides, and Bifidobacterium appear in the intestines of 40% of infant on the third day (68). On the 4th–7th days, Bifidobacterium became dominant, and its relative abundance is highest (68). Before weaning, the relative abundance of Bacteroides gradually increases to compete for Bifidobacterium in the infant intestine. After ingesting solid food, the composition of the infant gut microbiota is similar to that of adults (67). In 2–3 years after birth, the infant gut microbiota gradually develops towards the adult gut microbiota (66, 67).

3.2 The Driving Forces of the Infant Microbiota

The process from colonization to maturity of the gut microbiota is nonrandom and dynamic (69, 70). The process is affected by many factors during the perinatal period and early life, although it is difficult to quantify.

3.2.1 The Mode of Delivery

The mode of delivery is a crucial factor affecting vertical transmission (71). The composition of the gut microbiota of the infant delivered vaginally appears to be similar to that of the maternal vaginal microbiota: Lactobacillus dominates, followed by Senathia spp. and Prevotella. While the gut microbiota of infant delivered by cesarean section is similar to that of the maternal skin: Staphylococcus is dominant, followed by Propionibacterium and Corynebacterium (65, 72). Cesarean section leads to the imbalance of infant gut microbiota and the decrease of the diversity (73, 74). There was a study: researchers exposed infant delivered by cesarean section to vaginal fluid to promote the recovery of the infant gut microbiota. Interestingly, this approach effectively improves the oral, gut, and skin microbiota of infant delivered by cesarean section within 30 days after birth (75). This indicates that the vertical transmission of the maternal vaginal microbes can be reversed to some extent after birth.

It is worth noting that epidemiology has linked cesarean section to autoimmune diseases, asthma, obesity, and allergies (76). The difference in infant microbiota caused by vaginal delivery and cesarean section may be attributed to the “bacterial baptism” of vaginal fluid. Vaginal microbes spread vertically to the infant to promote the colonization of the infant microbes. However, there is another voice here: the differences in the infant microbiota caused by cesarean section may due to the use of antibiotics during delivery, the inactivity of the mother, and complications during pregnancy (77). The current studies may overestimate the effect of vaginal delivery on infant microbiota. Furthermore, the difference in infant microbiota caused by cesarean section is more moderate in rodents compared with humans. Of course, this may be caused by the spread of microbes in rodents more easily than in humans. Therefore, convincing evidence is necessary to clarify the differences in infant gut microbiota caused by the mode of delivery.

3.2.2 The Gestational Age at Birth

Gestational age at birth is also important for the colonization of infant microbiota. The immature microbiota poses a huge threat to premature because their immune and nervous systems are not yet fully developed. Usually, premature need to stay in the hospital for treatment. Factors such as the use of antibiotics and parenteral feeding can interfere with the natural establishment of infant microbiota. Compared with term infant, the intestines of premature cannot colonize symbiotic anaerobic bacteria such as Bacteroides and Bifidobacterium, and the relative abundance of Enterococcus and Enterobacteriaceae in their feces is increased (78–83). Studies showed that the gut microbiota of very low birth weight infant exhibits a transition from Bacilli to Gammaproteobacteria to Clostridia (84). The interaction between the immune system of premature infants and their immature microbiota may lead to inflammation and infectious diseases (85, 86). Compared with term infant, the SCFAs of the gut microbiota of preterm infant are significantly lower (81, 87). In short, the gestational age at birth affects the infant short-term health and even long-term health to a certain extent.

3.2.3 The Feeding Mode and Maternal Diet

The feeding mode is mainly associated with the infant gastrointestinal microbiota. The role of breastfeeding in regulating the gut microbiota of infant has been widely recognized (88, 89). In particular, the relative abundance of Bifidobacterium in the intestines of the breastfed infant is increased (90). On the one hand, breastfeeding provides infant with maternal microbes, nutrients, and antibacterial agents, which are important for infant health. On the other hand, the IgA in breast milk contributes to the “tolerability” and “regulation” of the infant immune system (91). It should be emphasized that human milk oligosaccharides (HMOs) in breast milk can selectively shape the formation of beneficial microbes in infant. The bioactive molecules and identified microbes in breast milk are shown in Table 2 (92–98). The gut microbiota of breast-fed infant is dominated by Bifidobacterium, while formula-fed is dominated by Bacteroides and Bifidobacterium (99). Besides, breastfeeding can effectively prevent infant from being overweight by improving the imbalance of the gut microbiota compared with formula-fed (100). Therefore, breast milk is the best food for babies. These also reflect the importance of infant microbiota in early health, and its impact on long-term health is also profound (101).

The maternal diet may affect the baby’s gut microbes through milk. Milk can be regarded as a kind of body fluid, and the maternal diet affects directly the microbial composition and diversity of breast milk (102, 103). During lactation, maternal fat consumption and fiber intake are important determinants of breast milk microbiota (104). Furthermore, maternal diet also affects the bioactive molecules in milk, such as HMOs (105). Therefore, breastfeeding mothers should diet carefully to give the best care to the baby.

3.2.4 The Environmental Factors

It is also meaningful to study the relationship between environmental factors and the colonization of microbiota in early life. Despite the lack of in-depth research, family members have been defined as potentially affecting the colonization of infant gut microbiota (63, 106). Interestingly, a Dutch study showed that the relative abundance of Bifidobacterium in the gut microbiota of infant with siblings (1 month old) is higher than that of those without siblings (107). In addition, the level of facultative anaerobes and anaerobes in the infant gut without big sisters is lower, while that of Clostridium and Escherichia coli is higher (108). A Danish study showed that the abundance and diversity of gut microbes of infant with siblings in early life are increased, while the influence of pets on them was not obvious (109). However, the concept of the “sibling effect” remains controversial because it is so extensive and difficult to quantify. Geographical location may also affect indirectly the microbiota in early life because geographic location determines eating habits and lifestyle (63, 110). For example, the diversity of infant microbiota living in rural Africa is significantly different from that of in cities (111).

3.2.5 Host Genetics

In recent years, the studies on host genetics and infant gut microbiota have gradually increased (112, 113). The most convincing evidence is that the microbial similarity of children with genetically identical twins (under 10 years of age) is higher than that of fraternal twins and unrelated controls (114). Additionally, the relative abundance of Bifidobacterium is associated with single nucleotide polymorphisms (SNPs) located at the LCT site of human genes (human lactase gene) (115). However, genetic factors are complex, and more evidence is needed to describe its association with the microbiota in early life.

4 Infant Gut Microbiota

In Table 3, we summarize the changes in the microbial composition of some parts of the infant body from delivery to postpartum (116). In early life, the infant gut microbiota undergo a transition from being dominated by Lactobacillus and Bifidobacterium to being dominated by Firmicutes and bacteria (117), which represents the gut microbiota from infancy to maturity. Lactobacillus and Bifidobacterium can promote the development of infant-acquired immunity and innate immunity in early life. Importantly, the relative abundance of Bifidobacterium in feces in early life is related to the risk of developing noncommunicable diseases in later life, such as obesity and asthma (118, 119). The composition and diversity of infant gut microbiota change dramatically with the intake of solid foods. The dietary fiber fermented by the gut microbiota produces SCFAs, which are related to the host’s immunity and metabolism (21, 120). Below, we introduce in detail the gut microbiota of infant.

4.1 The Dominant Populations of Infant Gut Microbiota

The adult gut microbiota are relatively stable (121), while the infant (less than 1 year old) have a lower diversity of gut microbiota compared with other age groups (110). Infant gut microbiota are dominated by Bifidobacterium, but there is great variability among individuals. According to the dominant population and composition, the core of infant gut microbiota is mainly divided into six groups (122): group 1, Bifidobacteriales, Lactobacillales, Anaerostipes, Clostridiales, and Faecalibacterium; group 2, Verrucomicrobiales and Bacteroidales; group 3, Clostridiales; group 4, Enterobacteriales; group 5, Pasteurellales; and group 6, Selenomonadales. In Table 4, we summarize the dominant populations and their functions of the infant gut microbiota.

4.1.1 Bifidobacteria

Bifidobacteria, belonging to the phylum Actinomycetes, anaerobic gram-positive bacilli, was isolated from the feces of the breastfed infant as early as 1899. At present, Bifidobacteria have been widely used in medicine and food. New strains are constantly being developed. At present, the ones that have been found to be closely related to infant health are Bifidobacterium breve and Bifidobacterium longum. The vertical transmission of the maternal Bifidobacterium to the offspring promotes its distribution in nature. The identification experiments of common Bifidobacterium in mothers and offspring confirmed this conclusion (69, 131).

HMOs in breast milk are natural prebiotics, and their absorption in the intestinal tract of infant mainly depends on Bifidobacteria (132). The evidence is that the level of HMOs in the feces of infant is negatively correlated with the level of Bifidobacteria. Interestingly, HMOs have no direct nutritional value for infant, and their important function is to shape the infant gut microbiota and benefit long-term health (133). After premature infant are supplemented with Bifidobacterium longum, the inflammatory response is weakened and the intestinal permeability is reduced (133). Premature infants supplemented with Bifidobacteria-based microbes can restore the gut microbiota to the level of term infant (134). Therefore, in early life, Bifidobacterium can effectively improve the health of infant, whether they are the premature infant or term infant.

4.1.2 The Genus Lactobacillus

The genus Lactobacillus are also known to be the dominant species in the infant gut microbiota and observed shortly after delivery (128). Various genus Lactobacillus are detected in meconium (the relative abundance: vaginal delivery is significantly greater than caesarean section), including Lactobacillus reuteri, Lactobacillus plantarum, Lactobacillus sakei, Lactobacillus brevis species, and Lactobacillus casei (135). Studies on the gut microbiota of infant in early life suggested that Lactobacillus gasseri and Lactobacillus rhamnosus are dominant in terms of the genus Lactobacillus (136). In addition to being abundantly present in the infant gut microbiota, the mother’s vagina and milk are also rich in the genus Lactobacillus. The former is passed vertically to the offspring during vaginal delivery and the latter is passed to the offspring during breastfeeding. The main types of the genus Lactobacillus in milk are L. plantarum and L. pentosus (137). As mentioned above, apart from Bifidobacteria, the genus Lactobacillus can also digest HMOs, and there are obvious differences in the ability of different strains to ferment HMOs (138). Furthermore, Lactobacillus reuteri DSM17938 has been shown to be effective in relieving colic of breast-fed infant (139).

4.1.3 The Genus Clostridium

The genus Clostridium can be divided into multiple genera, all of which belong to the Clostridia class. The genus Clostridium is the only genus of anaerobic bacillus, and their spores are round or ovoid, their diameter is wider than the bacteria. Most Clostridium species in the intestines of infants are pathogenic, especially Clostridium perfringens, Clostridium difficile, Clostridium tetani, and Clostridium botulinum (140). Clostridium species are common settler in infant intestine, but they are usually asymptomatic (141). The results of infant fecal microbial culture showed that the level of Clostridium perfringens and other clostridia may reach 107 CFU/g (142). A stool study of infant (<1 year old) in Jordan indicated that the colonization rate of Clostridium perfringens in the infant intestines is 27.2%, and the colonization rate of infant <6 months is higher (p < 0.004) (143). Interestingly, Rada et al. found that both the Clostridia and Bifidobacteria in the feces of infant (3–253Radadays old) grow vigorously on the prebiotic oligosaccharides, which may pose a challenge for supplementing prebiotics to infant lacking Bifidobacteria (144). In contrast, Enterococcus faecalis isolated from infant feces can inhibit the growth of Clostridium difficile, which may have potential applications for preventing Clostridium difficile colonization and infection (145). In short, in early life, we need to beware of Clostridium to prevent them from becoming the dominant species in infant gut microbiota.

However, Kim et al. found that neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens (146). The article pointed out that the administration of Clostridiales enhances the colonization resistance of the infant intestine, which can prevent some pathogens from attacking the infant intestine. Consistent with this, commensal Clostridia is considered to play an important role in maintaining intestinal homeostasis (147, 148). These data improve our understanding of the function of infant microbes. The application of Clostridia species to regulate the homeostasis of the infant intestinal microbiota is still a huge challenge, because most Clostridia are pathogenic.

4.1.4 The Genus Bacteroides

From birth to adulthood, the human microbiota gradually mature, among which the infant microbiota are usually characterized by a low total level. The relative abundance of Bacteroides in the infant feces delivered vaginally is higher than that of cesarean section (p < 0.01) (149). The diversity of Bacteroides in the feces of formula-fed infant is higher than that of breast-fed infant (150). Furthermore, the delayed colonization of Bacteroides caused by cesarean section may be associated with Th1 response (151). Similar to Bifidobacteria and the genus Lactobacillus, Bacteroides, and Fragilis in infant intestine can also digest HMOs (125). Additionally, in the environment of carbohydrates and HMOs, Bacteroides thetaiotaomicron promotes the growth of bacteria that produce SCFAs (152). However, some Bacteroides are pathogenic. For example, Bacteroides fragilis can cause anaerobic meningitis in infant (153). The abundance of Bacteroides in the intestine of allergic infant (<2 years old) is higher than that of allergic infant (154).

4.1.5 The Genus Veillonella and Streptococcus

The genus Veillonella are strictly anaerobic and parasitizes in the mouth, intestine, and respiratory tract of humans and animals (155). They can produce endotoxins and therefore play a role in various mixed infections. They are often detected from soft tissue abscesses and blood and are usually normal microbiota (155). The genus Veillonella is also common in the intestine of infants. In recent years, the new species have been identified continuously. For example, in 2018, Mashima et al. isolated a new type of anaerobic Gram-negative cocci strain from the biofilm of children’s tongue (156). Later, they found that the strain is different from the previous Veillonella species through genetic sequencing, and named it Veillonella infantium. An interesting study showed that the relative abundance of Veillonella in the intestine of infant (2–6 months old) exposed to unsafe food caused by Hurricane Maria is reduced (157).

The genus Streptococcus is another major group of common Gram-positive cocci in pyogenic cocci. There are 69 species and subspecies, which are widely distributed in nature and the nasopharynx, gastrointestinal tract of the human body, and most of them belong to normal genus (158). Pathogenic Streptococci can cause a variety of purulent inflammation and hypersensitivity diseases in humans, among which group B Streptococcus (GBS) are the most threatening to infants (159). Although antibiotics can reduce GBS level during delivery, GBS is still an important cause of neonatal sepsis in some high-income contexts (160). Approximately 35% of pregnant women carry GBS, and the gut microbiota of the offspring of mothers who carry GBS are significantly different from those of mothers who do not carry GBS (161). Therefore, effective prevention of the colonization of the GBS is essential for infant health.

4.1.6 The Genus Collinsella and Akkermansia

In the infant gut microbiota dominated by Bifidobacteria, the level of the genus Collinsella can be very high (129). So far, the genus Collins includes five species, all isolated from the human gastrointestinal tract: Collinsella stercoris, Collinsella intestinalis, Collinsella aerofaciens, Collinsella tanakaei, and Collinsella ihuae (162–164). Akkermansia muciniphila is the only specie of the genus Akkermansia in the gut microbiota, although its relative abundance is very low (165, 166). The level of Akkermansia muciniphila in the intestine rises rapidly after weaning and increases with age (167). Animal experiments indicated that the abundance of Akkermansia muciniphila in the intestine of obese and type 2 diabetic mice is reduced, and administration of Akkermansia muciniphila can control the inflammation and reduce intestinal permeability (168). Notably, Akkermansia muciniphila has also been found to be involved in the fermentation of HMOs.

5 The Role of Infant Microbiota in Future Health Planning

From birth, the gut microbiota are responsible for the activation and development of the immune system, the development of the central nervous system (CNS), and the digestion and metabolism of food. Early life is a critical period for microbial colonization, which not only affects the health of infant, but also is profound to long-term health planning (Figure 2). Below, we introduce in detail the relationship between infant gut microbiota and brain development and the shaping of the immune system. We also talk about the role of microbiota in early life in diseases and the direction of future study on human microbiota.

5.1 Infant Brain Development

Early life (less than 2 years old) is the period of rapid brain development. The brain volume of newborns is only about 1/3 the size of adults, but their brains will increase to 80%–90% of adults by the age of 2 (169). In early life, the infant brain undergoes successively the growth of axons and dendrites, the formation of synapses, the expansion of neurogliocyte, and the myelination of axons. Importantly, the first 2 years of life is also a golden period for the establishment of the gut microbiota. Therefore, the establishment of the gut microbiota in early life is essential for the development of the infant brain (169). In Figure 3, we briefly describe the role of the gut microbiota in the development of the CNS early in life (Figure 3).

Figure 3

There is a Chinese proverb: pull one hair and the whole body is affected. This sentence well reflects the role of the gut microbiota in brain development. What must be mentioned here is the ability of the metabolites or components of the microbiota to promote the development of the nervous system. These important molecules can enter the blood circulation through the intestinal barrier to affect brain development (170). For example, the indigenous spores produced by bacteria promote the synthesis of serotonin in enterochromaffin cells (ECs), thereby regulating the serotonin levels in the circulation, colon and ileum (171). Besides, SCFAs, the product of dietary fiber fermented by the gut microbiota, can directly regulate the sympathetic nervous system through free fatty acid receptors (belonging to G protein-coupled receptors) (21, 172). Kimura et al. found that SCFAs produced by the pregnant mother determine the development of the fetal intestine, pancreas, and nerves through GPR43 and GPR41 (173). SCFAs can also promote the maturation of microglia which differentiate retrogradely into other types of glial cells (174). Furthermore, the permeability of the blood-brain barrier (BBB) of germ-free mice is increased, and the administration of sodium butyrate (a type of SCFAs) improves the permeability defect of the BBB of germ-free mice by inhibiting histone deacetylases (HDACs) (175). In addition, the diversity of the gut microbiota is related to the release of intestinal peptides (such as oxytocin, ghrelin, glucagon-like peptide, cholecystokinin) (176). The disorder of the maternal gut microbiota causes the fetal brain to fail to develop normally, which is mediated by the metabolites of maternal gut microbes (177). The insufficiency of the gut microbiota is a great threat to premature babies because it weakens the ability of the intestinal wall to resist pathogens (170).

On the basis of its influence on brain development, the relationship between the gut microbiota and behavior in early life has also been established in recent years. For example, there are data showing that the diversity of the gut microbiota is associated with the cognitive ability of infant (170). In short, gut microbiota can shape the individual behaviors and social behaviors of infant (178).

5.2 Infant Immune System Development

Before birth, the maternal microbiota participate in regulating the innate immunity of the fetus. After birth, the infant microbiota continue to shape innate immunity and acquired immunity to promote the development of the immune system to a normal state.

5.2.1 Microbial Colonization Modulates Early Development of the Immune System in Mucosal Tissues

The microbiota on the mucosal surface in the early life changes dynamically until they reach an equilibrium point, then remain stable throughout long-term planning in the absence of external or internal insults (179). The colonization of microbes on the mucosal surface and the shaping of the immune system occur simultaneously in early life. Therefore, the microbiota on the mucosa may directly or indirectly shape the immune system until it matures. In Table 5, we summarize the gut microbes that have been identified in recent years to regulate intestinal mucosal immunity. The immune system of newborns is very different from that of adults, because infant preferentially develop tolerance in response to pathogen invasion (195–197). The period after birth is the most critical period, during which exposure to the microbiota may have a profound impact on the structure and function of the infant immune system.

5.2.2 The Mechanisms of the Microbiota Regulating Immunity

5.2.2.1 Microbial Metabolites

The metabolites of gut microbiota are diverse, and their sources include gut microbes digesting exogenous food components and fermenting endogenous compounds. These metabolites may act directly on the mucosa or enter the blood circulation through mucosal epithelial cells. The mechanism by which these metabolites modulate the immune response may be as follows (including but not limited to) (198): (1) Gut microbes digest dietary fiber to produce SCFAs which have wide-ranging effects on the immune system (Figure 4); (2) metabolites of gut microbes bind to specific receptors on host cells, including aryl hydrocarbon receptor (AHR), G protein-coupled receptors 41 and 43, Toll-like receptors (TLRs), and PXR receptors (see Table 5); (3) polyamines, such as spermine, putrescine, and spermidine, are involved in gene transcription and translation and exist in most living cells.

Figure 4

5.2.2.2 Microbial Components

Pattern recognition receptors (PRRs) are important components of innate immunity, which are responsible for responding, detecting, and coordinating self and nonself-antigens (198). PRRs can respond to the components of a variety of microbes (such as fungi, viruses, and bacteria), including peptidoglycans, lipopolysaccharides, formyl peptides, unique nucleic acid structures, and flagellin. The activation of PRRs promotes the release of chemokines, apoptotic factors, and cytokines through a signal cascade to participate in disease occurrence (199). We summarize briefly the mechanism by which microbial components modulate the immune response in Figure 5.

Figure 5

5.3 The Microbiota in Early Life as a Possible Predictor of the Human Health

From pregnancy to long-term planning, the microbiota plays an important role in the health of the baby. The normal microbiota of infant has a positive impact on the health in early life and long-term planning, while disturbance of the microbiota may be one of the causes of brain dysplasia, immune system defects, and metabolic disorders. In Table 6, we summarize the microbial metabolites or components related to diseases that have been identified in recent years. Therefore, the formation factors of the infant microbiota are essential for establishing targeted strategies to minimize the early interference and long-term effects on the human health (213).

At present, the colonization of infant gut microbiota has been widely recognized for its role in brain development and shaping the immune system. The communication between the normal gut microbiota and the host contributes to the metabolism and immunity in early life (214). It is worth mentioning that the lack of colonization of specific microbiota in early life may induce inflammatory or allergic diseases later, such as asthma and inflammatory bowel disease (IBD) (215). Interestingly, the maternal agricultural exposure during pregnancy can reduce the risk of asthma in the offspring (216). This may be mediated by the microbiota, because there is evidence that agricultural exposure in early life increases the diversity of the microbiota (217). Consistently, the use of antibiotics within the first 6 months of life increases the risk of asthma and allergies at 6 years of age (218). Besides, antibiotics administered to infant within 1 year of age are associated with the development of type 2 diabetes, type 1 diabetes, overweight, and eczema later, which is associated with infant microbiota (219–221). Shortly, these data support the connection between disturbances in the microbiota in early life and long-term health. However, the specific influencing factors and mechanisms need to be further explored.

5.4 Future Study Directions of Microbiota

5.4.1 Characterizing Microbiome Composition

At present, it is possible to directly classify microbial populations without culturing due to the emergence of high-throughput DNA sequencing technology. Also, 16s RNA technology provides a reliable method for studying complex microbiota. Based on this, characterizing microbiome composition is the primary direction for future research on the role of microbiota in disease and health.

5.4.2 Investigating the Function of Microbiota

Hypertranscriptome sequencing and macrogenomics laid the foundation for exploring the functions of the microbiota. The elucidation of the functions of the microbiota or specific microbes helps to regulate clearly the health or disease of the host.

5.4.3 Causation or Correlation Between Microbiota and Host Disease

The treatment method based on micro-ecological failed to achieve the expected results, causing many conclusions in this field to be questioned. The article published by Nature explains that host variables can interfere with microbiome research, prompting researchers to fully consider host variables in the subsequent research process (222). Therefore, the causal relationship or correlation between the microbiota and the host diseases needs urgently to be studied in depth (223).

5.4.4 Analysis of the Structure and Biological Activity of Microbial Metabolites or Components

The application of mass spectrometry and chromatography is of great significance for the exploration of microbial metabolites or components (224–226). Both targeted and untargeted proteomics and metabolomics are feasible for revealing the diversity of microbial metabolites or components. Exploring and identifying potential microbial metabolites or components provides opportunities for diagnosing and treating associated diseases.

5.4.5 Isolation of Individual Strains

The isolation of individual strains or species in microbial communities has always been a challenge. Accurately capturing and analyzing the characteristics of individual microbial species is necessary for the implementation of research on microbial communities.

5.4.6 Microbial Trace

The complex interaction between the microbiota and the host is a difficult point in the study. The trace of microbes provides “visual proof” for the ecological specificity of them. This method is expected to have a thorough understanding of the mechanism of action of the microbiota in the host.

6 Conclusions

The maternal microbiota are closely associated with the health of the fetus, and their disorder can lead to adverse pregnancy outcomes, including late abortion (LA), preterm rupture of membranes (PROM), hyperemesis gravidarum (HG), premature delivery (PTD), intrauterine growth restriction, and stillbirth. The maternal microbiota would be transmitted vertically to the newborn. The birth method, gestational age at birth, feeding method, and maternal factors all determine the colonization of the infant microbiota. The gut microbiota is the most important in the infant microbiota, and their cores are Bifidobacteria, the genus Lactobacillus, the genus Clostridium, the genus Bacteroides, the genus Veillonella and Streptococcus, and the genus Collinsella and Akkermansia. The microbiota in early life is essential for the brain development of offspring and the shaping of the immune system, which affects both infant health and long-term health. Therefore, from pregnancy to early life, reasonable intervention is important to regulate the maternal or offspring microbiota for offspring’s health.

Funding

This study was supported by the National Natural Science Foundation of China (Grant Nos. 82003761 and 81873838) and Zhejiang Provincial Natural Science Foundation of China (Grant No. LY16H160025).

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

• 1

  GoodrichJKDavenportERBeaumontMJacksonMAKnightROberCet al. Genetic Determinants of the Gut Microbiome in UK Twins. Cell Host Microbe (2016) 19(5):731–43. doi: 10.1016/j.chom.2016.04.017

  • CrossRef
  • Google Scholar

• 2

  ZhouPZhouYLiuBJinZZhuangXDaiWet al. Perinatal Antibiotic Exposure Affects the Transmission Between Maternal and Neonatal Microbiota and Is Associated With Early-Onset Sepsis. mSphere (2020) 5(1):e00984–19. doi: 10.1128/mSphere.00984-19

  • CrossRef
  • Google Scholar

• 3

  KimSKimHYimYSHaSAtarashiKTanTGet al. Maternal Gut Bacteria Promote Neurodevelopmental Abnormalities in Mouse Offspring. Nature (2017) 549(7673):528–32. doi: 10.1038/nature23910

  • CrossRef
  • Google Scholar

• 4

  JasarevicEHowardCDMisicAMBeitingDPBaleTL. Stress During Pregnancy Alters Temporal and Spatial Dynamics of the Maternal and Offspring Microbiome in a Sex-Specific Manner. Sci Rep (2017) 7:44182. doi: 10.1038/srep44182

  • CrossRef
  • Google Scholar

• 5

  CodagnoneMGStantonCO’MahonySMDinanTGCryanJF. Microbiota and Neurodevelopmental Trajectories: Role of Maternal and Early-Life Nutrition. Ann Nutr Metab (2019) 74 Suppl 2:16–27. doi: 10.1159/000499144

  • CrossRef
  • Google Scholar

• 6

  RomeroRHassanSSGajerPTarcaALFadroshDWNikitaLet al. The Composition and Stability of the Vaginal Microbiota of Normal Pregnant Women Is Different From That of Non-Pregnant Women. Microbiome (2014) 2(1):4. doi: 10.1186/2049-2618-2-4

  • CrossRef
  • Google Scholar

• 7

  MolinaNMSola-LeyvaAHaahrTAghajanovaLLaudanskiPCastillaJAet al. Analysing Endometrial Microbiome: Methodological Considerations and Recommendations for Good Practice. Hum Reprod (2021) 36(4):859–79. doi: 10.1093/humrep/deab009

  • CrossRef
  • Google Scholar

• 8

  QinSLiuYWangSMaJYangH. Distribution Characteristics of Intestinal Microbiota During Pregnancy and Postpartum in Healthy Women. J Matern Fetal Neonatal Med (2021) 1-8. doi: 10.1080/14767058.2020.1812571

  • CrossRef
  • Google Scholar

• 9

  IshimweJAAkinleyeAJohnsonACGarrettMRSasserJM. Gestational Gut Microbial Remodeling Is Impaired in a Rat Model of Preeclampsia Superimposed on Chronic Hypertension. Physiol Genomics (2021) 53(3):125–36. doi: 10.1152/physiolgenomics.00121.2020

  • CrossRef
  • Google Scholar

• 10

  AltemaniFBarrettHLGomez-ArangoLJoshPDavid McIntyreHCallawayLKet al. Pregnant Women Who Develop Preeclampsia Have Lower Abundance of the Butyrate-Producer Coprococcus in Their Gut Microbiota. Pregnancy Hypertens (2021) 23:211–9. doi: 10.1016/j.preghy.2021.01.002

  • CrossRef
  • Google Scholar

• 11

  AagaardKMaJAntonyKMGanuRPetrosinoJVersalovicJ. The Placenta Harbors a Unique Microbiome. Sci Transl Med (2014) 6(237):237ra65. doi: 10.1126/scitranslmed.3008599

  • CrossRef
  • Google Scholar

• 12

  PelzerEGomez-ArangoLFBarrettHLNitertMD. Review: Maternal Health and the Placental Microbiome. Placenta (2017) 54:30–7. doi: 10.1016/j.placenta.2016.12.003

  • CrossRef
  • Google Scholar

• 13

  de GoffauMCLagerSSovioUGaccioliFCookEPeacockSJet al. Human Placenta has No Microbiome But can Contain Potential Pathogens. Nature (2019) 572(7769):329–34. doi: 10.1038/s41586-019-1451-5

  • CrossRef
  • Google Scholar

• 14

  YaoYCaiXChenCFangHZhaoYFeiWet al. The Role of Microbiomes in Pregnant Women and Offspring: Research Progress of Recent Years. Front Pharmacol (2020) 11:643. doi: 10.3389/fphar.2020.00643

  • CrossRef
  • Google Scholar

• 15

  NugentBMBaleTL. The Omniscient Placenta: Metabolic and Epigenetic Regulation of Fetal Programming. Front Neuroendocrinol (2015) 39:28–37. doi: 10.1016/j.yfrne.2015.09.001

  • CrossRef
  • Google Scholar

• 16

  LainKYCatalanoPM. Metabolic Changes in Pregnancy. Clin Obstet Gynecol (2007) 50(4):938–48. doi: 10.1097/GRF.0b013e31815a5494

  • CrossRef
  • Google Scholar

• 17

  KorenOGoodrichJKCullenderTCSporALaitinenKBackhedHKet al. Host Remodeling of the Gut Microbiome and Metabolic Changes During Pregnancy. Cell (2012) 150(3):470–80. doi: 10.1016/j.cell.2012.07.008

  • CrossRef
  • Google Scholar

• 18

  NeumanHKorenO. The Pregnancy Microbiome. Nestle Nutr Inst Workshop Ser (2017) 88:1–9. doi: 10.1159/000455207

  • CrossRef
  • Google Scholar

• 19

  Nuriel-OhayonMNeumanHKorenO. Microbial Changes During Pregnancy, Birth, and Infancy. Front Microbiol (2016) 7:1031. doi: 10.3389/fmicb.2016.01031

  • CrossRef
  • Google Scholar

• 20

  LeBlancJGMilaniCde GioriGSSesmaFvan SinderenDVenturaM. Bacteria as Vitamin Suppliers to Their Host: A Gut Microbiota Perspective. Curr Opin Biotechnol (2013) 24(2):160–8. doi: 10.1016/j.copbio.2012.08.005

  • CrossRef
  • Google Scholar

• 21

  YaoYCaiXFeiWYeYZhaoMZhengC. The Role of Short-Chain Fatty Acids in Immunity, Inflammation and Metabolism. Crit Rev Food Sci Nutr (2020) 1–12. doi: 10.1080/10408398.2020.1854675

  • CrossRef
  • Google Scholar

• 22

  PalladinoEVan MieghemTConnorKL. Diet Alters Micronutrient Pathways in the Gut and Placenta That Regulate Fetal Growth and Development in Pregnant Mice. Reprod Sci (2021) 28(2):447–61. doi: 10.1007/s43032-020-00297-1

  • CrossRef
  • Google Scholar

• 23

  ChoiGBYimYSWongHKimSKimHKimSVet al. The Maternal Interleukin-17a Pathway in Mice Promotes Autism-Like Phenotypes in Offspring. Science (2016) 351(6276):933–9. doi: 10.1126/science.aad0314

  • CrossRef
  • Google Scholar

• 24

  IvanovIIAtarashiKManelNBrodieELShimaTKaraozUet al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria. Cell (2009) 139(3):485–98. doi: 10.1016/j.cell.2009.09.033

  • CrossRef
  • Google Scholar

• 25

  RomeroR. Prenatal Medicine: The Child Is the Father of the Man. 1996. J Matern Fetal Neonatal Med (2009) 22(8):636–9. doi: 10.1080/14767050902784171

  • CrossRef
  • Google Scholar

• 26

  LawnJECousensSZupanJLancet Neonatal Survival Steering T. 4 Million Neonatal Deaths: When? Where? Why? Lancet (2005) 365(9462):891–900. doi: 10.1016/S0140-6736(05)71048-5

  • CrossRef
  • Google Scholar

• 27

  GoldenbergRLHauthJCAndrewsWW. Intrauterine Infection and Preterm Delivery. N Engl J Med (2000) 342(20):1500–7. doi: 10.1056/NEJM200005183422007

  • CrossRef
  • Google Scholar

• 28

  Garcia-GrauISimonCMorenoI. Uterine Microbiome-Low Biomass and High Expectationsdagger. Biol Reprod (2019) 101(6):1102–14. doi: 10.1093/biolre/ioy257

  • CrossRef
  • Google Scholar

• 29

  WattsDHKrohnMAHillierSLEschenbachDA. The Association of Occult Amniotic Fluid Infection With Gestational Age and Neonatal Outcome Among Women in Preterm Labor. Obstet Gynecol (1992) 79(3):351–7. doi: 10.1097/00006250-199203000-00005

  • CrossRef
  • Google Scholar

• 30

  TheisKRRomeroRMotomuraKGalazJWintersADPacoraPet al. Microbial Burden and Inflammasome Activation in Amniotic Fluid of Patients With Preterm Prelabor Rupture of Membranes. J Perinat Med (2020) 48(2):115–31. doi: 10.1515/jpm-2019-0398

  • CrossRef
  • Google Scholar

• 31

  RomeroRMirandaJChaemsaithongPChaiworapongsaTKusanovicJPDongZet al. Sterile and Microbial-Associated Intra-Amniotic Inflammation in Preterm Prelabor Rupture of Membranes. J Matern Fetal Neonatal Med (2015) 28(12):1394–409. doi: 10.3109/14767058.2014.958463

  • CrossRef
  • Google Scholar

• 32

  EsplinMSRomeroRChaiworapongsaTKimYMEdwinSGomezRet al. Monocyte Chemotactic Protein-1 Is Increased in the Amniotic Fluid of Women Who Deliver Preterm in the Presence or Absence of Intra-Amniotic Infection. J Matern Fetal Neonatal Med (2005) 17(6):365–73. doi: 10.1080/14767050500141329

  • CrossRef
  • Google Scholar

• 33

  HillierSLWitkinSSKrohnMAWattsDHKiviatNBEschenbachDA. The Relationship of Amniotic Fluid Cytokines and Preterm Delivery, Amniotic Fluid Infection, Histologic Chorioamnionitis, and Chorioamnion Infection. Obstet Gynecol (1993) 81(6):941–8.

  • Google Scholar

• 34

  MendzGLKaakoushNOQuinlivanJA. Bacterial Aetiological Agents of Intra-Amniotic Infections and Preterm Birth in Pregnant Women. Front Cell Infect Microbiol (2013) 3:58. doi: 10.3389/fcimb.2013.00058

  • CrossRef
  • Google Scholar

• 35

  DiGiulioDB. Diversity of Microbes in Amniotic Fluid. Semin Fetal Neonatal Med (2012) 17(1):2–11. doi: 10.1016/j.siny.2011.10.001

  • CrossRef
  • Google Scholar

• 36

  MancabelliLTarracchiniCMilaniCLugliGAFontanaFTurroniFet al. Vaginotypes of the Human Vaginal Microbiome. Environ Microbiol (2021) 23(3):1780–92. doi: 10.1111/1462-2920.15441

  • CrossRef
  • Google Scholar

• 37

  AnahtarMNGootenbergDBMitchellCMKwonDS. Cervicovaginal Microbiota and Reproductive Health: The Virtue of Simplicity. Cell Host Microbe (2018) 23(2):159–68. doi: 10.1016/j.chom.2018.01.013

  • CrossRef
  • Google Scholar

• 38

  FettweisJMSerranoMGBrooksJPEdwardsDJGirerdPHParikhHIet al. The Vaginal Microbiome and Preterm Birth. Nat Med (2019) 25(6):1012–21. doi: 10.1038/s41591-019-0450-2

  • CrossRef
  • Google Scholar

• 39

  BrownRGAl-MemarMMarchesiJRLeeYSSmithAChanDet al. Establishment of Vaginal Microbiota Composition in Early Pregnancy and Its Association With Subsequent Preterm Prelabor Rupture of the Fetal Membranes. Transl Res (2019) 207:30–43. doi: 10.1016/j.trsl.2018.12.005

  • CrossRef
  • Google Scholar

• 40

  ElovitzMAGajerPRiisVBrownAGHumphrysMSHolmJBet al. Cervicovaginal Microbiota and Local Immune Response Modulate the Risk of Spontaneous Preterm Delivery. Nat Commun (2019) 10(1):1305. doi: 10.1038/s41467-019-09285-9

  • CrossRef
  • Google Scholar

• 41

  AbdelmaksoudAAKopardeVNShethNUSerranoMGGlascockALFettweisJMet al. Comparison of Lactobacillus Crispatus Isolates From Lactobacillus-Dominated Vaginal Microbiomes With Isolates From Microbiomes Containing Bacterial Vaginosis-Associated Bacteria. Microbiol (Reading) (2016) 162(3):466–75. doi: 10.1099/mic.0.000238

  • CrossRef
  • Google Scholar

• 42

  StoutMJZhouYWylieKMTarrPIMaconesGATuuliMG. Early Pregnancy Vaginal Microbiome Trends and Preterm Birth. Am J Obstet Gynecol (2017) 217(3):356 e1–356 e18. doi: 10.1016/j.ajog.2017.05.030

  • CrossRef
  • Google Scholar

• 43

  TabatabaeiNErenAMBarreiroLBYotovaVDumaineAAllardCet al. Vaginal Microbiome in Early Pregnancy and Subsequent Risk of Spontaneous Preterm Birth: A Case-Control Study. BJOG (2019) 126(3):349–58. doi: 10.1111/1471-0528.15299

  • CrossRef
  • Google Scholar

• 44

  HanCLiHHanLWangCYanYQiWet al. Aerobic Vaginitis in Late Pregnancy and Outcomes of Pregnancy. Eur J Clin Microbiol Infect Dis (2019) 38(2):233–9. doi: 10.1007/s10096-018-3416-2

  • CrossRef
  • Google Scholar

• 45

  JulianaNCASuitersMJMAl-NasirySMorreSAPetersRPHAmbrosinoE. The Association Between Vaginal Microbiota Dysbiosis, Bacterial Vaginosis, and Aerobic Vaginitis, and Adverse Pregnancy Outcomes of Women Living in Sub-Saharan Africa: A Systematic Review. Front Public Health (2020) 8:567885. doi: 10.3389/fpubh.2020.567885

  • CrossRef
  • Google Scholar

• 46

  SmithBKempMEthelbergSSchiellerupPBruunBGGerner-SmidtPet al. Listeria Monocytogenes: Maternal-Foetal Infections in Denmark 1994-2005. Scand J Infect Dis (2009) 41(1):21–5. doi: 10.1080/00365540802468094

  • CrossRef
  • Google Scholar

• 47

  El AilaNATencyIClaeysGVerstraelenHSaerensBSantiagoGLet al. Identification and Genotyping of Bacteria From Paired Vaginal and Rectal Samples From Pregnant Women Indicates Similarity Between Vaginal and Rectal Microflora. BMC Infect Dis (2009) 9:167. doi: 10.1186/1471-2334-9-167

  • CrossRef
  • Google Scholar

• 48

  LiuYChenHFengLZhangJ. Interactions Between Gut Microbiota and Metabolites Modulate Cytokine Network Imbalances in Women With Unexplained Miscarriage. NPJ Biofilms Microbiomes (2021) 7(1):24. doi: 10.1038/s41522-021-00199-3

  • CrossRef
  • Google Scholar

• 49

  GershuniVLiYElovitzMLiHWuGDCompherCW. Maternal Gut Microbiota Reflecting Poor Diet Quality Is Associated With Spontaneous Preterm Birth in a Prospective Cohort Study. Am J Clin Nutr (2021) 113(3):602–11. doi: 10.1093/ajcn/nqaa361

  • CrossRef
  • Google Scholar

• 50

  SweeneyELKallapurSGGisslenTLambersDSChougnetCAStephensonSAet al. Placental Infection With Ureaplasma Species Is Associated With Histologic Chorioamnionitis and Adverse Outcomes in Moderately Preterm and Late-Preterm Infants. J Infect Dis (2016) 213(8):1340–7. doi: 10.1093/infdis/jiv587

  • CrossRef
  • Google Scholar

• 51

  PrinceALMaJKannanPSAlvarezMGisslenTHarrisRAet al. The Placental Membrane Microbiome Is Altered Among Subjects With Spontaneous Preterm Birth With and Without Chorioamnionitis. Am J Obstet Gynecol (2016) 214(5):627.e1–627.e16. doi: 10.1016/j.ajog.2016.01.193

  • CrossRef
  • Google Scholar

• 52

  SterpuIFranssonEHugerthLWDuJPereiraMChengLet al. No Evidence for a Placental Microbiome in Human Pregnancies at Term. Am J Obstet Gynecol (2021) 224(3):296.e1–296.e23. doi: 10.1016/j.ajog.2020.08.103

  • CrossRef
  • Google Scholar

• 53

  KupermanAAZimmermanAHamadiaSZivOGurevichVFichtmanBet al. Deep Microbial Analysis of Multiple Placentas Shows No Evidence for a Placental Microbiome. BJOG (2020) 127(2):159–69. doi: 10.1111/1471-0528.15896

  • CrossRef
  • Google Scholar

• 54

  CobbCMKellyPJWilliamsKBBabbarSAngolkarMDermanRJ. The Oral Microbiome and Adverse Pregnancy Outcomes. Int J Womens Health (2017) 9:551–9. doi: 10.2147/IJWH.S142730

  • CrossRef
  • Google Scholar

• 55

  TavarnaTPhillipsPLWuXJReyesL. Fetal Growth Restriction Is a Host Specific Response to Infection With an Impaired Spiral Artery Remodeling-Inducing Strain of Porphyromonas Gingivalis. Sci Rep (2020) 10(1):14606. doi: 10.1038/s41598-020-71762-9

  • CrossRef
  • Google Scholar

• 56

  ChanomethapornAChayasadomAWara-AswapatiNKongwattanakulKSuwannarongWTangwanichgapongKet al. Association Between Periodontitis and Spontaneous Abortion: A Case-Control Study. J Periodontol (2019) 90(4):381–90. doi: 10.1002/JPER.18-0174

  • CrossRef
  • Google Scholar

• 57

  YeCKobayashiHKatagiriSMiyasakaNTakeuchiYKurajiRet al. The Relationship Between the Anti-Porphyromonas Gingivalis Immunoglobulin G Subclass Antibody and Small for Gestational Age Delivery: A Longitudinal Study in Pregnant Japanese Women. Int Dent J (2020) 70(4):296–302. doi: 10.1111/idj.12548

  • CrossRef
  • Google Scholar

• 58

  DaalderopLAWielandBVTomsinKReyesLKramerBWVanterpoolSFet al. Periodontal Disease and Pregnancy Outcomes: Overview of Systematic Reviews. JDR Clin Trans Res (2018) 3(1):10–27. doi: 10.1177/2380084417731097

  • CrossRef
  • Google Scholar

• 59

  MaekawaTKraussJLAbeTJotwaniRTriantafilouMTriantafilouKet al. Porphyromonas Gingivalis Manipulates Complement and TLR Signaling to Uncouple Bacterial Clearance From Inflammation and Promote Dysbiosis. Cell Host Microbe (2014) 15(6):768–78. doi: 10.1016/j.chom.2014.05.012

  • CrossRef
  • Google Scholar

• 60

  JiaLHanNDuJGuoLLuoZLiuY. Pathogenesis of Important Virulence Factors of Porphyromonas Gingivalis via Toll-Like Receptors. Front Cell Infect Microbiol (2019) 9:262. doi: 10.3389/fcimb.2019.00262

  • CrossRef
  • Google Scholar

• 61

  ChengWCHughesFJTaamsLS. The Presence, Function and Regulation of IL-17 and Th17 Cells in Periodontitis. J Clin Periodontol (2014) 41(6):541–9. doi: 10.1111/jcpe.12238

  • CrossRef
  • Google Scholar

• 62

  ChopraARadhakrishnanRSharmaM. Porphyromonas Gingivalis and Adverse Pregnancy Outcomes: A Review on its Intricate Pathogenic Mechanisms. Crit Rev Microbiol (2020) 46(2):213–36. doi: 10.1080/1040841X.2020.1747392

  • CrossRef
  • Google Scholar

• 63

  RodriguezJMMurphyKStantonCRossRPKoberOIJugeNet al. The Composition of the Gut Microbiota Throughout Life, With an Emphasis on Early Life. Microb Ecol Health Dis (2015) 26:26050. doi: 10.3402/mehd.v26.26050

  • CrossRef
  • Google Scholar

• 64

  KorpelaKde VosWM. Early Life Colonization of the Human Gut: Microbes Matter Everywhere. Curr Opin Microbiol (2018) 44:70–8. doi: 10.1016/j.mib.2018.06.003

  • CrossRef
  • Google Scholar

• 65

  Dominguez-BelloMGCostelloEKContrerasMMagrisMHidalgoGFiererNet al. Delivery Mode Shapes the Acquisition and Structure of the Initial Microbiota Across Multiple Body Habitats in Newborns. Proc Natl Acad Sci USA (2010) 107(26):11971–5. doi: 10.1073/pnas.1002601107

  • CrossRef
  • Google Scholar

• 66

  TamburiniSShenNWuHCClementeJC. The Microbiome in Early Life: Implications for Health Outcomes. Nat Med (2016) 22(7):713–22. doi: 10.1038/nm.4142

  • CrossRef
  • Google Scholar

• 67

  ClementeJCUrsellLKParfreyLWKnightR. The Impact of the Gut Microbiota on Human Health: An Integrative View. Cell (2012) 148(6):1258–70. doi: 10.1016/j.cell.2012.01.035

  • CrossRef
  • Google Scholar

• 68

  MitsuokaT. Intestinal Flora and Human Health. Asia Pac J Clin Nutr (1996) 5(1):2–9.

  • Google Scholar

• 69

  AvershinaELundgardKSekeljaMDotterudCStorroOOienTet al. Transition From Infant- to Adult-Like Gut Microbiota. Environ Microbiol (2016) 18(7):2226–36. doi: 10.1111/1462-2920.13248

  • CrossRef
  • Google Scholar

• 70

  AvershinaEStorroOOienTJohnsenRWilsonREgelandTet al. Bifidobacterial Succession and Correlation Networks in a Large Unselected Cohort of Mothers and Their Children. Appl Environ Microbiol (2013) 79(2):497–507. doi: 10.1128/AEM.02359-12

  • CrossRef
  • Google Scholar

• 71

  YangRGaoRCuiSZhongHZhangXChenYet al. Dynamic Signatures of Gut Microbiota and Influences of Delivery and Feeding Modes During the First 6 Months of Life. Physiol Genomics (2019) 51(8):368–78. doi: 10.1152/physiolgenomics.00026.2019

  • CrossRef
  • Google Scholar

• 72

  Montoya-WilliamsDLemasDJSpirydaLPatelKCarneyOONeuJet al. The Neonatal Microbiome and Its Partial Role in Mediating the Association Between Birth by Cesarean Section and Adverse Pediatric Outcomes. Neonatology (2018) 114(2):103–11. doi: 10.1159/000487102

  • CrossRef
  • Google Scholar

• 73

  AkagawaSTsujiSOnumaCAkagawaYYamaguchiTYamagishiMet al. Effect of Delivery Mode and Nutrition on Gut Microbiota in Neonates. Ann Nutr Metab (2019) 74(2):132–9. doi: 10.1159/000496427

  • CrossRef
  • Google Scholar

• 74

  ReymanMvan HoutenMAvan BaarleDBoschAManWHChuMet al. Impact of Delivery Mode-Associated Gut Microbiota Dynamics on Health in the First Year of Life. Nat Commun (2019) 10(1):4997. doi: 10.1038/s41467-019-13014-7

  • CrossRef
  • Google Scholar

• 75

  Dominguez-BelloMGDe Jesus-LaboyKMShenNCoxLMAmirAGonzalezAet al. Partial Restoration of the Microbiota of Cesarean-Born Infants via Vaginal Microbial Transfer. Nat Med (2016) 22(3):250–3. doi: 10.1038/nm.4039

  • CrossRef
  • Google Scholar

• 76

  StokholmJThorsenJBlaserMJRasmussenMAHjelmsoMShahSet al. Delivery Mode and Gut Microbial Changes Correlate With an Increased Risk of Childhood Asthma. Sci Transl Med (2020) 12(569):eaax9929. doi: 10.1126/scitranslmed.aax9929

  • CrossRef
  • Google Scholar

• 77

  StinsonLFPayneMSKeelanJA. A Critical Review of the Bacterial Baptism Hypothesis and the Impact of Cesarean Delivery on the Infant Microbiome. Front Med (Lausanne) (2018) 5:135. doi: 10.3389/fmed.2018.00135

  • CrossRef
  • Google Scholar

• 78

  HillCJLynchDBMurphyKUlaszewskaMJefferyIBO’SheaCAet al. Evolution of Gut Microbiota Composition From Birth to 24 Weeks in the INFANTMET Cohort. Microbiome (2017) 5(1):4. doi: 10.1186/s40168-016-0213-y

  • CrossRef
  • Google Scholar

• 79

  RougeCGoldenbergOFerrarisLBergerBRochatFLegrandAet al. Investigation of the Intestinal Microbiota in Preterm Infants Using Different Methods. Anaerobe (2010) 16(4):362–70. doi: 10.1016/j.anaerobe.2010.06.002

  • CrossRef
  • Google Scholar

• 80

  JacquotANeveuDAujoulatFMercierGMarchandinHJumas-BilakEet al. Dynamics and Clinical Evolution of Bacterial Gut Microflora in Extremely Premature Patients. J Pediatr (2011) 158(3):390–6. doi: 10.1016/j.jpeds.2010.09.007

  • CrossRef
  • Google Scholar

• 81

  ArboleyaSBinettiASalazarNFernandezNSolisGHernandez-BarrancoAet al. Establishment and Development of Intestinal Microbiota in Preterm Neonates. FEMS Microbiol Ecol (2012) 79(3):763–72. doi: 10.1111/j.1574-6941.2011.01261.x

  • CrossRef
  • Google Scholar

• 82

  ArboleyaSSanchezBMilaniCDurantiSSolisGFernandezNet al. Intestinal Microbiota Development in Preterm Neonates and Effect of Perinatal Antibiotics. J Pediatr (2015) 166(3):538–44. doi: 10.1016/j.jpeds.2014.09.041

  • CrossRef
  • Google Scholar

• 83

  CongXXuWJantonSHendersonWAMatsonAMcGrathJMet al. Gut Microbiome Developmental Patterns in Early Life of Preterm Infants: Impacts of Feeding and Gender. PloS One (2016) 11(4):e0152751. doi: 10.1371/journal.pone.0152751

  • CrossRef
  • Google Scholar

• 84

  La RosaPSWarnerBBZhouYWeinstockGMSodergrenEHall-MooreCMet al. Patterned Progression of Bacterial Populations in the Premature Infant Gut. Proc Natl Acad Sci USA (2014) 111(34):12522–7. doi: 10.1073/pnas.1409497111

  • CrossRef
  • Google Scholar

• 85

  ColladoMCCernadaMNeuJPerez-MartinezGGormazMVentoM. Factors Influencing Gastrointestinal Tract and Microbiota Immune Interaction in Preterm Infants. Pediatr Res (2015) 77(6):726–31. doi: 10.1038/pr.2015.54

  • CrossRef
  • Google Scholar

• 86

  TorrazzaRMNeuJ. The Altered Gut Microbiome and Necrotizing Enterocolitis. Clin Perinatol (2013) 40(1):93–108. doi: 10.1016/j.clp.2012.12.009

  • CrossRef
  • Google Scholar

• 87

  ArboleyaSSanchezBSolisGFernandezNSuarezMHernandez-BarrancoAMet al. Impact of Prematurity and Perinatal Antibiotics on the Developing Intestinal Microbiota: A Functional Inference Study. Int J Mol Sci (2016) 17(5):649. doi: 10.3390/ijms17050649

  • CrossRef
  • Google Scholar

• 88

  O’SullivanAFarverMSmilowitzJT. The Influence of Early Infant-Feeding Practices on the Intestinal Microbiome and Body Composition in Infants. Nutr Metab Insights (2015) 8(Suppl 1):1–9. doi: 10.4137/NMI.S29530

  • CrossRef
  • Google Scholar

• 89

  LiNXieQZhaoLShiJEvivieSELvXet al. Human Milk and Infant Formula Modulate the Intestinal Microbiota and Immune Systems of Human Microbiota-Associated Mice. Food Funct (2021) 12(6):2784–98. doi: 10.1039/d0fo03004j

  • CrossRef
  • Google Scholar

• 90

  BezirtzoglouETsiotsiasAWellingGW. Microbiota Profile in Feces of Breast- and Formula-Fed Newborns by Using Fluorescence. Situ Hybridization (FISH) Anaerobe (2011) 17(6):478–82. doi: 10.1016/j.anaerobe.2011.03.009

  • CrossRef
  • Google Scholar

• 91

  MaynardCLElsonCOHattonRDWeaverCT. Reciprocal Interactions of the Intestinal Microbiota and Immune System. Nature (2012) 489(7415):231–41. doi: 10.1038/nature11551

  • CrossRef
  • Google Scholar

• 92

  BodeLMcGuireMRodriguezJMGeddesDTHassiotouFHartmannPEet al. It’s Alive: Microbes and Cells in Human Milk and Their Potential Benefits to Mother and Infant. Adv Nutr (2014) 5(5):571–3. doi: 10.3945/an.114.006643

  • CrossRef
  • Google Scholar

• 93

  LonnerdalB. Bioactive Proteins in Human Milk: Mechanisms of Action. J Pediatr (2010) 156(2 Suppl):S26–30. doi: 10.1016/j.jpeds.2009.11.017

  • CrossRef
  • Google Scholar

• 94

  WalkerA. Breast Milk as the Gold Standard for Protective Nutrients. J Pediatr (2010) 156(2 Suppl):S3–7. doi: 10.1016/j.jpeds.2009.11.021

  • CrossRef
  • Google Scholar

• 95

  FernandezLRuizLJaraJOrgazBRodriguezJM. Strategies for the Preservation, Restoration and Modulation of the Human Milk Microbiota. Implications for Human Milk Banks and Neonatal Intensive Care Units. Front Microbiol (2018) 9:2676. doi: 10.3389/fmicb.2018.02676

  • CrossRef
  • Google Scholar

• 96

  Khodayar-PardoPMira-PascualLColladoMCMartinez-CostaC. Impact of Lactation Stage, Gestational Age and Mode of Delivery on Breast Milk Microbiota. J Perinatol (2014) 34(8):599–605. doi: 10.1038/jp.2014.47

  • CrossRef
  • Google Scholar

• 97

  BallardOMorrowAL. Human Milk Composition: Nutrients and Bioactive Factors. Pediatr Clin North Am (2013) 60(1):49–74. doi: 10.1016/j.pcl.2012.10.002

  • CrossRef
  • Google Scholar

• 98

  CachoNTLawrenceRM. Innate Immunity and Breast Milk. Front Immunol (2017) 8:584. doi: 10.3389/fimmu.2017.00584

  • CrossRef
  • Google Scholar

• 99

  HarmsenHJWildeboer-VelooACRaangsGCWagendorpAAKlijnNBindelsJGet al. Analysis of Intestinal Flora Development in Breast-Fed and Formula-Fed Infants by Using Molecular Identification and Detection Methods. J Pediatr Gastroenterol Nutr (2000) 30(1):61–7. doi: 10.1097/00005176-200001000-00019

  • CrossRef
  • Google Scholar

• 100

  ForbesJDAzadMBVehlingLTunHMKonyaTBGuttmanDSet al. Association of Exposure to Formula in the Hospital and Subsequent Infant Feeding Practices With Gut Microbiota and Risk of Overweight in the First Year of Life. JAMA Pediatr (2018) 172(7):e181161. doi: 10.1001/jamapediatrics.2018.1161

  • CrossRef
  • Google Scholar

• 101

  AlsharairiNA. The Infant Gut Microbiota and Risk of Asthma: The Effect of Maternal Nutrition During Pregnancy and Lactation. Microorganisms (2020) 8(8):1119. doi: 10.3390/microorganisms8081119

  • CrossRef
  • Google Scholar

• 102

  MaherSEO’BrienECMooreRLByrneDFGeraghtyAASaldovaRet al. The Association Between the Maternal Diet and the Maternal and Infant Gut Microbiome: A Systematic Review. Br J Nutr (2020) 1–29. doi: 10.1017/S0007114520000847

  • CrossRef
  • Google Scholar

• 103

  Cortes-MaciasESelma-RoyoMGarcia-MantranaICalatayudMGonzalezSMartinez-CostaCet al. Maternal Diet Shapes the Breast Milk Microbiota Composition and Diversity: Impact of Mode of Delivery and Antibiotic Exposure. J Nutr (2021) 151(2):330–40. doi: 10.1093/jn/nxaa310

  • CrossRef
  • Google Scholar

• 104

  LeMay-NedjelskiLAsburyMRButcherJLeySHHanleyAJKissAet al. Maternal Diet and Infant Feeding Practices Are Associated With Variation in the Human Milk Microbiota at 3 Months Postpartum in a Cohort of Women With High Rates of Gestational Glucose Intolerance. J Nutr (2021) 151(2):320–9. doi: 10.1093/jn/nxaa248

  • CrossRef
  • Google Scholar

• 105

  SeferovicMDMohammadMPaceRMEngevikMVersalovicJBodeLet al. Maternal Diet Alters Human Milk Oligosaccharide Composition With Implications for the Milk Metagenome. Sci Rep (2020) 10(1):22092. doi: 10.1038/s41598-020-79022-6

  • CrossRef
  • Google Scholar

• 106

  FouhyFRossRPFitzgeraldGFStantonCCotterPD. Composition of the Early Intestinal Microbiota: Knowledge, Knowledge Gaps and the Use of High-Throughput Sequencing to Address These Gaps. Gut Microbes (2012) 3(3):203–20. doi: 10.4161/gmic.20169

  • CrossRef
  • Google Scholar

• 107

  PendersJThijsCVinkCStelmaFFSnijdersBKummelingIet al. Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy. Pediatrics (2006) 118(2):511–21. doi: 10.1542/peds.2005-2824

  • CrossRef
  • Google Scholar

• 108

  AdlerberthIStrachanDPMatricardiPMAhrneSOrfeiLAbergNet al. Gut Microbiota and Development of Atopic Eczema in 3 European Birth Cohorts. J Allergy Clin Immunol (2007) 120(2):343–50. doi: 10.1016/j.jaci.2007.05.018

  • CrossRef
  • Google Scholar

• 109

  LaursenMFZachariassenGBahlMIBergstromAHostAMichaelsenKFet al. Having Older Siblings Is Associated With Gut Microbiota Development During Early Childhood. BMC Microbiol (2015) 15:154. doi: 10.1186/s12866-015-0477-6

  • CrossRef
  • Google Scholar

• 110

  ArrietaMCStiemsmaLTAmenyogbeNBrownEMFinlayB. The Intestinal Microbiome in Early Life: Health and Disease. Front Immunol (2014) 5:427(427). doi: 10.3389/fimmu.2014.00427

  • CrossRef
  • Google Scholar

• 111

  De FilippoCCavalieriDDi PaolaMRamazzottiMPoulletJBMassartSet al. Impact of Diet in Shaping Gut Microbiota Revealed by a Comparative Study in Children From Europe and Rural Africa. Proc Natl Acad Sci USA (2010) 107(33):14691–6. doi: 10.1073/pnas.1005963107

  • CrossRef
  • Google Scholar

• 112

  BensonAKKellySALeggeRMaFLowSJKimJet al. Individuality in Gut Microbiota Composition Is a Complex Polygenic Trait Shaped by Multiple Environmental and Host Genetic Factors. Proc Natl Acad Sci USA (2010) 107(44):18933–8. doi: 10.1073/pnas.1007028107

  • CrossRef
  • Google Scholar

• 113

  TurpinWEspin-GarciaOXuWSilverbergMSKevansDSmithMIet al. Association of Host Genome With Intestinal Microbial Composition in a Large Healthy Cohort. Nat Genet (2016) 48(11):1413–7. doi: 10.1038/ng.3693

  • CrossRef
  • Google Scholar

• 114

  StewartJAChadwickVSMurrayA. Investigations Into the Influence of Host Genetics on the Predominant Eubacteria in the Faecal Microflora of Children. J Med Microbiol (2005) 54(Pt 12):1239–42. doi: 10.1099/jmm.0.46189-0

  • CrossRef
  • Google Scholar

• 115

  KeXWalkerAHaangeSBLagkouvardosILiuYSchmitt-KopplinPet al. Synbiotic-Driven Improvement of Metabolic Disturbances Is Associated With Changes in the Gut Microbiome in Diet-Induced Obese Mice. Mol Metab (2019) 22:96–109. doi: 10.1016/j.molmet.2019.01.012

  • CrossRef
  • Google Scholar

• 116

  PlovierHEverardADruartCDepommierCVan HulMGeurtsLet al. A Purified Membrane Protein From Akkermansia Muciniphila or the Pasteurized Bacterium Improves Metabolism in Obese and Diabetic Mice. Nat Med (2017) 23(1):107–13. doi: 10.1038/nm.4236

  • CrossRef
  • Google Scholar

• 117

  PalmerCBikEMDiGiulioDBRelmanDABrownPO. Development of the Human Infant Intestinal Microbiota. PloS Biol (2007) 5(7):e177. doi: 10.1371/journal.pbio.0050177

  • CrossRef
  • Google Scholar

• 118

  BjorkstenBSeppEJulgeKVoorTMikelsaarM. Allergy Development and the Intestinal Microflora During the First Year of Life. J Allergy Clin Immunol (2001) 108(4):516–20. doi: 10.1067/mai.2001.118130

  • CrossRef
  • Google Scholar

• 119

  KalliomakiMColladoMCSalminenSIsolauriE. Early Differences in Fecal Microbiota Composition in Children may Predict Overweight. Am J Clin Nutr (2008) 87(3):534–8. doi: 10.1093/ajcn/87.3.534

  • CrossRef
  • Google Scholar

• 120

  KoenigJESporAScalfoneNFrickerADStombaughJKnightRet al. Succession of Microbial Consortia in the Developing Infant Gut Microbiome. Proc Natl Acad Sci USA (2011) 108 Suppl 1:4578–85. doi: 10.1073/pnas.1000081107

  • CrossRef
  • Google Scholar

• 121

  ClaessonMJCusackSO’SullivanOGreene-DinizRde WeerdHFlanneryEet al. Composition, Variability, and Temporal Stability of the Intestinal Microbiota of the Elderly. Proc Natl Acad Sci U.S.A. (2011) 108 Suppl 1:4586–91. doi: 10.1073/pnas.1000097107

  • CrossRef
  • Google Scholar

• 122

  VallesYArtachoAPascual-GarciaAFerrusMLGosalbesMJAbellanJJet al. Microbial Succession in the Gut: Directional Trends of Taxonomic and Functional Change in a Birth Cohort of Spanish Infants. PloS Genet (2014) 10(6):e1004406. doi: 10.1371/journal.pgen.1004406

  • CrossRef
  • Google Scholar

• 123

  YassourMVatanenTSiljanderHHamalainenAMHarkonenTRyhanenSJet al. Natural History of the Infant Gut Microbiome and Impact of Antibiotic Treatment on Bacterial Strain Diversity and Stability. Sci Transl Med (2016) 8(343):343ra81. doi: 10.1126/scitranslmed.aad0917

  • CrossRef
  • Google Scholar

• 124

  MilaniCDurantiSBottaciniFCaseyETurroniFMahonyJet al. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Microbiol Mol Biol Rev (2017) 81(4):507-14. doi: 10.1128/MMBR.00036-17

  • CrossRef
  • Google Scholar

• 125

  MarcobalABarbozaMSonnenburgEDPudloNMartensECDesaiPet al. Bacteroides in the Infant Gut Consume Milk Oligosaccharides via Mucus-Utilization Pathways. Cell Host Microbe (2011) 10(5):507–14. doi: 10.1016/j.chom.2011.10.007

  • CrossRef
  • Google Scholar

• 126

  ArumugamMRaesJPelletierELe PaslierDYamadaTMendeDRet al. Enterotypes of the Human Gut Microbiome. Nature (2011) 473(7346):174–80. doi: 10.1038/nature09944

  • CrossRef
  • Google Scholar

• 127

  VipperlaKO’KeefeSJ. The Microbiota and its Metabolites in Colonic Mucosal Health and Cancer Risk. Nutr Clin Pract (2012) 27(5):624–35. doi: 10.1177/0884533612452012

  • CrossRef
  • Google Scholar

• 128

  SolisGde Los Reyes-GavilanCGFernandezNMargollesAGueimondeM. Establishment and Development of Lactic Acid Bacteria and Bifidobacteria Microbiota in Breast-Milk and the Infant Gut. Anaerobe (2010) 16(3):307–10. doi: 10.1016/j.anaerobe.2010.02.004

  • CrossRef
  • Google Scholar

• 129

  DograSSakwinskaOSohSENgom-BruCBruckWMBergerBet al. Dynamics of Infant Gut Microbiota Are Influenced by Delivery Mode and Gestational Duration and Are Associated With Subsequent Adiposity. mBio (2015) 6(1):e02419-14. doi: 10.1128/mBio.02419-14

  • CrossRef
  • Google Scholar

• 130

  ChaH. [Experiences of a Social Therapist. Endlessly, Limitlessly Addicted]. Krankenpfl Soins Infirm (1994) 87(8):50–1.

  • Google Scholar

• 131

  MilaniCMancabelliLLugliGADurantiSTurroniFFerrarioCet al. Exploring Vertical Transmission of Bifidobacteria From Mother to Child. Appl Environ Microbiol (2015) 81(20):7078–87. doi: 10.1128/AEM.02037-15

  • CrossRef
  • Google Scholar

• 132

  SakanakaMGotohAYoshidaKOdamakiTKoguchiHXiaoJZet al. Varied Pathways of Infant Gut-Associated Bifidobacterium to Assimilate Human Milk Oligosaccharides: Prevalence of the Gene Set and Its Correlation With Bifidobacteria-Rich Microbiota Formation. Nutrients (2019) 12(1):71. doi: 10.3390/nu12010071

  • CrossRef
  • Google Scholar

• 133

  UnderwoodMAGermanJBLebrillaCBMillsDA. Bifidobacterium Longum Subspecies Infantis: Champion Colonizer of the Infant Gut. Pediatr Res (2015) 77(1-2):229–35. doi: 10.1038/pr.2014.156

  • CrossRef
  • Google Scholar

• 134

  Alcon-GinerCDalbyMJCaimSKetskemetyJShawASimKet al. Microbiota Supplementation With Bifidobacterium and Lactobacillus Modifies the Preterm Infant Gut Microbiota and Metabolome: An Observational Study. Cell Rep Med (2020) 1(5):100077. doi: 10.1016/j.xcrm.2020.100077

  • CrossRef
  • Google Scholar

• 135

  NagpalRTsujiHTakahashiTKawashimaKNagataSNomotoKet al. Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section. Front Microbiol (2016) 7:1997. doi: 10.3389/fmicb.2016.01997

  • CrossRef
  • Google Scholar

• 136

  YangBChenYStantonCRossRPLeeYKZhaoJet al. Bifidobacterium and Lactobacillus Composition at Species Level and Gut Microbiota Diversity in Infants Before 6 Weeks. Int J Mol Sci (2019) 20(13):3306. doi: 10.3390/ijms20133306

  • CrossRef
  • Google Scholar

• 137

  JamyuangCPhoonlapdachaPChongviriyaphanNChanputWNitisinprasertSNakphaichitM. Characterization and Probiotic Properties of Lactobacilli From Human Breast Milk. 3 Biotech (2019) 9(11):398. doi: 10.1007/s13205-019-1926-y

  • CrossRef
  • Google Scholar

• 138

  ThongaramTHoeflingerJLChowJMillerMJ. Human Milk Oligosaccharide Consumption by Probiotic and Human-Associated Bifidobacteria and Lactobacilli. J Dairy Sci (2017) 100(10):7825–33. doi: 10.3168/jds.2017-12753

  • CrossRef
  • Google Scholar

• 139

  SungVD’AmicoFCabanaMDChauKKorenGSavinoFet al. Lactobacillus Reuteri to Treat Infant Colic: A Meta-Analysis. Pediatrics (2018) 141(1):e20171811. doi: 10.1542/peds.2017-1811

  • CrossRef
  • Google Scholar

• 140

  KiuRCaimSAlcon-GinerCBeltekiGClarkePPickardDet al. Preterm Infant-Associated Clostridium Tertium, Clostridium Cadaveris, and Clostridium Paraputrificum Strains: Genomic and Evolutionary Insights. Genome Biol Evol (2017) 9(10):2707–14. doi: 10.1093/gbe/evx210

  • CrossRef
  • Google Scholar

• 141

  CuiQQYangJNiuYNQiangCXLiZRXuKYet al. Epidemiological Investigation of Clostridioides Difficile Colonization in Chinese Community Infants. Anaerobe (2019) 56:116–23. doi: 10.1016/j.anaerobe.2019.01.008

  • CrossRef
  • Google Scholar

• 142

  Mevissen-VerhageEAMarcelisJHde VosMNHarmsen-van AmerongenWCVerhoefJ. Bifidobacterium, Bacteroides, and Clostridium Spp. In Fecal Samples From Breast-Fed and Bottle-Fed Infants With and Without Iron Supplement. J Clin Microbiol (1987) 25(2):285–9. doi: 10.1128/JCM.25.2.285-289.1987

  • CrossRef
  • Google Scholar

• 143

  Al RadaidehAJBadranEFShehabiAA. Diversity of Toxin Genotypes and Antimicrobial Susceptibility of Clostridium Perfringens Isolates From Feces of Infants. Germs (2019) 9(1):28–34. doi: 10.18683/germs.2019.1154

  • CrossRef
  • Google Scholar

• 144

  RadaVNevoralJTrojanovaITomankovaESmehilovaMKillerJ. Growth of Infant Faecal Bifidobacteria and Clostridia on Prebiotic Oligosaccharides in In Vitro Conditions. Anaerobe (2008) 14(4):205–8. doi: 10.1016/j.anaerobe.2008.05.003

  • CrossRef
  • Google Scholar

• 145

  RomyasamitCThatrimontrichaiAAroonkesornAChanketWIngviyaNSaengsuwanPet al. Enterococcus Faecalis Isolated From Infant Feces Inhibits Toxigenic Clostridioides (Clostridium) Difficile. Front Pediatr (2020) 8:572633. doi: 10.3389/fped.2020.572633

  • CrossRef
  • Google Scholar

• 146

  KimYGSakamotoKSeoSUPickardJMGillillandMG3rdPudloNAet al. Neonatal Acquisition of Clostridia Species Protects Against Colonization by Bacterial Pathogens. Science (2017) 356(6335):315–9. doi: 10.1126/science.aag2029

  • CrossRef
  • Google Scholar

• 147

  LopetusoLRScaldaferriFPetitoVGasbarriniA. Commensal Clostridia: Leading Players in the Maintenance of Gut Homeostasis. Gut Pathog (2013) 5(1):23. doi: 10.1186/1757-4749-5-23

  • CrossRef
  • Google Scholar

• 148

  MauriceCFHaiserHJTurnbaughPJ. Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome. Cell (2013) 152(1-2):39–50. doi: 10.1016/j.cell.2012.10.052

  • CrossRef
  • Google Scholar

• 149

  GregoryKELaPlanteRDShanGKumarDVGregasM. Mode of Birth Influences Preterm Infant Intestinal Colonization With Bacteroides Over the Early Neonatal Period. Adv Neonatal Care (2015) 15(6):386–93. doi: 10.1097/ANC.0000000000000237

  • CrossRef
  • Google Scholar

• 150

  SanchezEDe PalmaGCapillaANovaEPozoTCastillejoGet al. Influence of Environmental and Genetic Factors Linked to Celiac Disease Risk on Infant Gut Colonization by Bacteroides Species. Appl Environ Microbiol (2011) 77(15):5316–23. doi: 10.1128/AEM.00365-11

  • CrossRef
  • Google Scholar

• 151

  JakobssonHEAbrahamssonTRJenmalmMCHarrisKQuinceCJernbergCet al. Decreased Gut Microbiota Diversity, Delayed Bacteroidetes Colonisation and Reduced Th1 Responses in Infants Delivered by Caesarean Section. Gut (2014) 63(4):559–66. doi: 10.1136/gutjnl-2012-303249

  • CrossRef
  • Google Scholar

• 152

  ChiaLWMankMBlijenbergBAalvinkSBongersRSStahlBet al. Bacteroides Thetaiotaomicron Fosters the Growth of Butyrate-Producing Anaerostipes Caccae in the Presence of Lactose and Total Human Milk Carbohydrates. Microorganisms (2020) 8(10):1513. doi: 10.3390/microorganisms8101513

  • CrossRef
  • Google Scholar

• 153

  FarahSAlshehriMAAlfawazTSAhmadMAlshahraniDA. Bacteroides Fragilis Meningitis in a Saudi Infant: Case Report and Literature Review. Int J Pediatr Adolesc Med (2018) 5(3):122–6. doi: 10.1016/j.ijpam.2018.05.003

  • CrossRef
  • Google Scholar

• 154

  SuzukiSShimojoNTajiriYKumemuraMKohnoY. A Quantitative and Relative Increase in Intestinal Bacteroides in Allergic Infants in Rural Japan. Asian Pac J Allergy Immunol (2008) 26(2-3):113–9.

  • Google Scholar

• 155

  FengDNeuweilerINogueiraRNackenhorstU. Modeling of Symbiotic Bacterial Biofilm Growth With an Example of the Streptococcus-Veillonella Sp. System. Bull Math Biol (2021) 83(5):48. doi: 10.1007/s11538-021-00888-2

  • CrossRef
  • Google Scholar

• 156

  MashimaILiaoYCMiyakawaHTheodoreaCFThawboonBThaweboonSet al. Veillonella Infantium Sp. Nov., an Anaerobic, Gram-Stain-Negative Coccus Isolated From Tongue Biofilm of a Thai Child. Int J Syst Evol Microbiol (2018) 68(4):1101–6. doi: 10.1099/ijsem.0.002632

  • CrossRef
  • Google Scholar

• 157

  WangLde Angel SolaDAcevedo FloresMSchrieferAWangLGeronimo LopezKet al. Prenatal Food Insecurity Post Hurricane Maria Is Associated With Decreased Veillonella in the Infant Gut. Pediatr Res (2020) 88(6):917–24. doi: 10.1038/s41390-020-0839-0

  • CrossRef
  • Google Scholar

• 158

  SaadRTsoiKOnacIADaviesKAHajelaVKTacuC. Streptococcus-Associated Vasculitis: A Role for Antibiotic Therapy? IDCases (2021) 24:e01071. doi: 10.1016/j.idcr.2021.e01071

  • CrossRef
  • Google Scholar

• 159

  PuopoloKMLynfieldRCummingsJJCommittee OnF. Newborn, and Committee On Infectious D. Management of Infants at Risk for Group B Streptococcal Disease. Pediatrics (2019) 144(2):e20191881. doi: 10.1542/peds.2019-1881

  • CrossRef
  • Google Scholar

• 160

  MadridLSealeACKohli-LynchMEdmondKMLawnJEHeathPTet al. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-Analyses. Clin Infect Dis (2017) 65(suppl_2):S160–72. doi: 10.1093/cid/cix656

  • CrossRef
  • Google Scholar

• 161

  Cassidy-BushrowAESitarikALevinAMLynchSVHavstadSOwnbyDRet al. Maternal Group B Streptococcus and the Infant Gut Microbiota. J Dev Orig Health Dis (2016) 7(1):45–53. doi: 10.1017/S2040174415001361

  • CrossRef
  • Google Scholar

• 162

  KageyamaABennoYNakaseT. Phylogenetic and Phenotypic Evidence for the Transfer of Eubacterium Aerofaciens to the Genus Collinsella as Collinsella Aerofaciens Gen. Nov., Comb. Nov. Int J Syst Bacteriol (1999) 49 Pt 2:557–65. doi: 10.1099/00207713-49-2-557

  • CrossRef
  • Google Scholar

• 163

  NagaiFWatanabeYMorotomiM. Slackia Piriformis Sp. Nov. And Collinsella Tanakaei Sp. Nov., New Members of the Family Coriobacteriaceae, Isolated From Human Faeces. Int J Syst Evol Microbiol (2010) 60(Pt 11):2639–46. doi: 10.1099/ijs.0.017533-0

  • CrossRef
  • Google Scholar

• 164

  DurandGACadoretFLagierJCFournierPERaoultD. Description of ‘Gorbachella Massiliensis’ Gen. Nov., Sp. Nov., ‘Fenollaria Timonensis’ Sp. Nov., ‘Intestinimonas Timonensis’ Sp. Nov. And ‘Collinsella Ihuae’ Sp. Nov. Isolated From Healthy Fresh Stools With Culturomics. New Microbes New Infect (2017) 16:60–2. doi: 10.1016/j.nmni.2017.01.005

  • CrossRef
  • Google Scholar

• 165

  DerrienMColladoMCBen-AmorKSalminenSde VosWM. The Mucin Degrader Akkermansia Muciniphila Is an Abundant Resident of the Human Intestinal Tract. Appl Environ Microbiol (2008) 74(5):1646–8. doi: 10.1128/AEM.01226-07

  • CrossRef
  • Google Scholar

• 166

  DerrienMVaughanEEPluggeCMde VosWM. Akkermansia Muciniphila Gen. Nov., Sp. Nov., a Human Intestinal Mucin-Degrading Bacterium. Int J Syst Evol Microbiol (2004) 54(Pt 5):1469–76. doi: 10.1099/ijs.0.02873-0

  • CrossRef
  • Google Scholar

• 167

  ColladoMCDerrienMIsolauriEde VosWMSalminenS. Intestinal Integrity and Akkermansia Muciniphila, a Mucin-Degrading Member of the Intestinal Microbiota Present in Infants, Adults, and the Elderly. Appl Environ Microbiol (2007) 73(23):7767–70. doi: 10.1128/AEM.01477-07

  • CrossRef
  • Google Scholar

• 168

  EverardABelzerCGeurtsLOuwerkerkJPDruartCBindelsLBet al. Cross-Talk Between Akkermansia Muciniphila and Intestinal Epithelium Controls Diet-Induced Obesity. Proc Natl Acad Sci USA (2013) 110(22):9066–71. doi: 10.1073/pnas.1219451110

  • CrossRef
  • Google Scholar

• 169

  Diaz HeijtzR. Fetal, Neonatal, and Infant Microbiome: Perturbations and Subsequent Effects on Brain Development and Behavior. Semin Fetal Neonatal Med (2016) 21(6):410–7. doi: 10.1016/j.siny.2016.04.012

  • CrossRef
  • Google Scholar

• 170

  LuJClaudEC. Connection Between Gut Microbiome and Brain Development in Preterm Infants. Dev Psychobiol (2019) 61(5):739–51. doi: 10.1002/dev.21806

  • CrossRef
  • Google Scholar

• 171

  YanoJMYuKDonaldsonGPShastriGGAnnPMaLet al. Indigenous Bacteria From the Gut Microbiota Regulate Host Serotonin Biosynthesis. Cell (2015) 161(2):264–76. doi: 10.1016/j.cell.2015.02.047

  • CrossRef
  • Google Scholar

• 172

  MullerPASchneebergerMMatheisFWangPKernerZIlangesAet al. Microbiota Modulate Sympathetic Neurons via a Gut-Brain Circuit. Nature (2020) 583(7816):441–6. doi: 10.1038/s41586-020-2474-7

  • CrossRef
  • Google Scholar

• 173

  KimuraIMiyamotoJOhue-KitanoRWatanabeKYamadaTOnukiMet al. Maternal Gut Microbiota in Pregnancy Influences Offspring Metabolic Phenotype in Mice. Science (2020) 367(6481):eaaw8429. doi: 10.1126/science.aaw8429

  • CrossRef
  • Google Scholar

• 174

  ErnyDHrabe de AngelisALJaitinDWieghoferPStaszewskiODavidEet al. Host Microbiota Constantly Control Maturation and Function of Microglia in the CNS. Nat Neurosci (2015) 18(7):965–77. doi: 10.1038/nn.4030

  • CrossRef
  • Google Scholar

• 175

  BranisteVAl-AsmakhMKowalCAnuarFAbbaspourATothMet al. The Gut Microbiota Influences Blood-Brain Barrier Permeability in Mice. Sci Transl Med (2014) 6(263):263ra158. doi: 10.1126/scitranslmed.3009759

  • CrossRef
  • Google Scholar

• 176

  LachGSchellekensHDinanTGCryanJF. Anxiety, Depression, and the Microbiome: A Role for Gut Peptides. Neurotherapeutics (2018) 15(1):36–59. doi: 10.1007/s13311-017-0585-0

  • CrossRef
  • Google Scholar

• 177

  VuongHEPronovostGNWilliamsDWColeyEJLSieglerELQiuAet al. The Maternal Microbiome Modulates Fetal Neurodevelopment in Mice. Nature (2020) 586(7828):281–6. doi: 10.1038/s41586-020-2745-3

  • CrossRef
  • Google Scholar

• 178

  SampsonTRMazmanianSK. Control of Brain Development, Function, and Behavior by the Microbiome. Cell Host Microbe (2015) 17(5):565–76. doi: 10.1016/j.chom.2015.04.011

  • CrossRef
  • Google Scholar

• 179

  SporAKorenOLeyR. Unravelling the Effects of the Environment and Host Genotype on the Gut Microbiome. Nat Rev Microbiol (2011) 9(4):279–90. doi: 10.1038/nrmicro2540

  • CrossRef
  • Google Scholar

• 180

  ZelanteTIannittiRGCunhaCDe LucaAGiovanniniGPieracciniGet al. Tryptophan Catabolites From Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22. Immunity (2013) 39(2):372–85. doi: 10.1016/j.immuni.2013.08.003

  • CrossRef
  • Google Scholar

• 181

  MetidjiAOmenettiSCrottaSLiYNyeERossEet al. The Environmental Sensor AHR Protects From Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity. Immunity (2019) 50(6):1542. doi: 10.1016/j.immuni.2019.05.024

  • CrossRef
  • Google Scholar

• 182

  WlodarskaMLuoCKoldeRd’HennezelEAnnandJWHeimCEet al. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation. Cell Host Microbe (2017) 22(1):25–37.e6. doi: 10.1016/j.chom.2017.06.007

  • CrossRef
  • Google Scholar

• 183

  VenkateshMMukherjeeSWangHLiHSunKBenechetAPet al. Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-Like Receptor 4. Immunity (2014) 41(2):296–310. doi: 10.1016/j.immuni.2014.06.014

  • CrossRef
  • Google Scholar

• 184

  AlcainoCKnutsonKRTreichelAJYildizGStregePRLindenDRet al. A Population of Gut Epithelial Enterochromaffin Cells is Mechanosensitive and Requires Piezo2 to Convert Force Into Serotonin Release. Proc Natl Acad Sci USA (2018) 115(32):E7632–41. doi: 10.1073/pnas.1804938115

  • CrossRef
  • Google Scholar

• 185

  PedicordVALockhartAAKRanganKJCraigJWLoschkoJRogozAet al. Exploiting a Host-Commensal Interaction to Promote Intestinal Barrier Function and Enteric Pathogen Tolerance. Sci Immunol (2016) 1(3):eaai7732. doi: 10.1126/sciimmunol.aai7732

  • CrossRef
  • Google Scholar

• 186

  HemmiHTakeuchiOKawaiTKaishoTSatoSSanjoHet al. A Toll-Like Receptor Recognizes Bacterial DNA. Nature (2000) 408(6813):740–5. doi: 10.1038/35047123

  • CrossRef
  • Google Scholar

• 187

  CasanovaJE. Bacterial Autophagy: Offense and Defense at the Host-Pathogen Interface. Cell Mol Gastroenterol Hepatol (2017) 4(2):237–43. doi: 10.1016/j.jcmgh.2017.05.002

  • CrossRef
  • Google Scholar

• 188

  ZhuSDingSWangPWeiZPanWPalmNWet al. Nlrp9b Inflammasome Restricts Rotavirus Infection in Intestinal Epithelial Cells. Nature (2017) 546(7660):667–70. doi: 10.1038/nature22967

  • CrossRef
  • Google Scholar

• 189

  ShiHKokoevaMVInouyeKTzameliIYinHFlierJS. TLR4 Links Innate Immunity and Fatty Acid-Induced Insulin Resistance. J Clin Invest (2006) 116(11):3015–25. doi: 10.1172/JCI28898

  • CrossRef
  • Google Scholar

• 190

  FriedrichCMamareliPThiemannSKruseFWangZHolzmannBet al. MyD88 Signaling in Dendritic Cells and the Intestinal Epithelium Controls Immunity Against Intestinal Infection With C. Rodentium. PloS Pathog (2017) 13(5):e1006357. doi: 10.1371/journal.ppat.1006357

  • CrossRef
  • Google Scholar

• 191

  MurakamiTOckingerJYuJBylesVMcCollAHoferAMet al. Critical Role for Calcium Mobilization in Activation of the NLRP3 Inflammasome. Proc Natl Acad Sci USA (2012) 109(28):11282–7. doi: 10.1073/pnas.1117765109

  • CrossRef
  • Google Scholar

• 192

  GrazianiFPujolANicolettiCDouSMarescaMGiardinaTet al. Ruminococcus Gnavus E1 Modulates Mucin Expression and Intestinal Glycosylation. J Appl Microbiol (2016) 120(5):1403–17. doi: 10.1111/jam.13095

  • CrossRef
  • Google Scholar

• 193

  ZhaoYYangJShiJGongYNLuQXuHet al. The NLRC4 Inflammasome Receptors for Bacterial Flagellin and Type III Secretion Apparatus. Nature (2011) 477(7366):596–600. doi: 10.1038/nature10510

  • CrossRef
  • Google Scholar

• 194

  SaavedraPHVHuangLGhazaviFKourulaSVanden BergheTTakahashiNet al. Apoptosis of Intestinal Epithelial Cells Restricts Clostridium Difficile Infection in a Model of Pseudomembranous Colitis. Nat Commun (2018) 9(1):4846. doi: 10.1038/s41467-018-07386-5

  • CrossRef
  • Google Scholar

• 195

  RidgeJPFuchsEJMatzingerP. Neonatal Tolerance Revisited: Turning on Newborn T Cells With Dendritic Cells. Science (1996) 271(5256):1723–6. doi: 10.1126/science.271.5256.1723

  • CrossRef
  • Google Scholar

• 196

  ForsthuberTYipHCLehmannPV. Induction of TH1 and TH2 Immunity in Neonatal Mice. Science (1996) 271(5256):1728–30. doi: 10.1126/science.271.5256.1728

  • CrossRef
  • Google Scholar

• 197

  SarzottiMRobbinsDSHoffmanPM. Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus. Science (1996) 271(5256):1726–8. doi: 10.1126/science.271.5256.1726

  • CrossRef
  • Google Scholar

• 198

  RooksMGGarrettWS. Gut Microbiota, Metabolites and Host Immunity. Nat Rev Immunol (2016) 16(6):341–52. doi: 10.1038/nri.2016.42

  • CrossRef
  • Google Scholar

• 199

  YuanMJiangZBiGNomuraKLiuMWangYet al. Pattern-Recognition Receptors Are Required for NLR-Mediated Plant Immunity. Nature (2021) 592(7852):105–9. doi: 10.1038/s41586-021-03316-6

  • CrossRef
  • Google Scholar

• 200

  DonohoeDRHolleyDCollinsLBMontgomerySAWhitmoreACHillhouseAet al. A Gnotobiotic Mouse Model Demonstrates That Dietary Fiber Protects Against Colorectal Tumorigenesis in a Microbiota- and Butyrate-Dependent Manner. Cancer Discov (2014) 4(12):1387–97. doi: 10.1158/2159-8290.CD-14-0501

  • CrossRef
  • Google Scholar

• 201

  JohnsonCHDejeaCMEdlerDHoangLTSantidrianAFFeldingBHet al. Metabolism Links Bacterial Biofilms and Colon Carcinogenesis. Cell Metab (2015) 21(6):891–7. doi: 10.1016/j.cmet.2015.04.011

  • CrossRef
  • Google Scholar

• 202

  SrinivasanSMorganMTFiedlerTLDjukovicDHoffmanNGRafteryDet al. Metabolic Signatures of Bacterial Vaginosis. mBio (2015) 6(2):e00204-15. doi: 10.1128/mBio.00204-15

  • CrossRef
  • Google Scholar

• 203

  VoltoliniCBattersbySEtheringtonSLPetragliaFNormanJEJabbourHN. A Novel Antiinflammatory Role for the Short-Chain Fatty Acids in Human Labor. Endocrinology (2012) 153(1):395–403. doi: 10.1210/en.2011-1457

  • CrossRef
  • Google Scholar

• 204

  TrompetteAGollwitzerESYadavaKSichelstielAKSprengerNNgom-BruCet al. Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis. Nat Med (2014) 20(2):159–66. doi: 10.1038/nm.3444

  • CrossRef
  • Google Scholar

• 205

  ThorburnANMcKenzieCIShenSStanleyDMaciaLMasonLJet al. Evidence That Asthma Is a Developmental Origin Disease Influenced by Maternal Diet and Bacterial Metabolites. Nat Commun (2015) 6:7320. doi: 10.1038/ncomms8320

  • CrossRef
  • Google Scholar

• 206

  SinghNGuravASivaprakasamSBradyEPadiaRShiHet al. Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis. Immunity (2014) 40(1):128–39. doi: 10.1016/j.immuni.2013.12.007

  • CrossRef
  • Google Scholar

• 207

  HsiaoEYMcBrideSWHsienSSharonGHydeERMcCueTet al. Microbiota Modulate Behavioral and Physiological Abnormalities Associated With Neurodevelopmental Disorders. Cell (2013) 155(7):1451–63. doi: 10.1016/j.cell.2013.11.024

  • CrossRef
  • Google Scholar

• 208

  SchugarRCShihDMWarrierMHelsleyRNBurrowsAFergusonDet al. The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue. Cell Rep (2017) 19(12):2451–61. doi: 10.1016/j.celrep.2017.05.077

  • CrossRef
  • Google Scholar

• 209

  MeijersBKClaesKBammensBde LoorHViaeneLVerbekeKet al. P-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease. Clin J Am Soc Nephrol (2010) 5(7):1182–9. doi: 10.2215/CJN.07971109

  • CrossRef
  • Google Scholar

• 210

  TanaseDMGosavEMNeculaeECosteaCFCiocoiuMHurjuiLLet al. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM). Nutrients (2020) 12(12):3719. doi: 10.3390/nu12123719

  • CrossRef
  • Google Scholar

• 211

  KoethRAWangZLevisonBSBuffaJAOrgESheehyBTet al. Intestinal Microbiota Metabolism of L-Carnitine, a Nutrient in Red Meat, Promotes Atherosclerosis. Nat Med (2013) 19(5):576–85. doi: 10.1038/nm.3145

  • CrossRef
  • Google Scholar

• 212

  BuffieCGBucciVSteinRRMcKenneyPTLingLGobourneAet al. Precision Microbiome Reconstitution Restores Bile Acid Mediated Resistance to Clostridium Difficile. Nature (2015) 517(7533):205–8. doi: 10.1038/nature13828

  • CrossRef
  • Google Scholar

• 213

  SaavedraJMDattiloAM. Early Development of Intestinal Microbiota: Implications for Future Health. Gastroenterol Clin North Am (2012) 41(4):717–31. doi: 10.1016/j.gtc.2012.08.001

  • CrossRef
  • Google Scholar

• 214

  HoughtelingPDWalkerWA. Why Is Initial Bacterial Colonization of the Intestine Important to Infants’ and Children’s Health? J Pediatr Gastroenterol Nutr (2015) 60(3):294–307. doi: 10.1097/MPG.0000000000000597

  • CrossRef
  • Google Scholar

• 215

  OlszakTAnDZeissigSVeraMPRichterJFrankeAet al. Microbial Exposure During Early Life has Persistent Effects on Natural Killer T Cell Function. Science (2012) 336(6080):489–93. doi: 10.1126/science.1219328

  • CrossRef
  • Google Scholar

• 216

  TwardziokMSchroderPCKruscheJCasacaVIIlliSBockAet al. Asthmatic Farm Children Show Increased CD3(+)CD8(low) T-Cells Compared to Non-Asthmatic Farm Children. Clin Immunol (2017) 183:285–92. doi: 10.1016/j.clim.2017.09.009

  • CrossRef
  • Google Scholar

• 217

  DicksvedJFloistrupHBergstromARosenquistMPershagenGScheyniusAet al. Molecular Fingerprinting of the Fecal Microbiota of Children Raised According to Different Lifestyles. Appl Environ Microbiol (2007) 73(7):2284–9. doi: 10.1128/AEM.02223-06

  • CrossRef
  • Google Scholar

• 218

  RisnesKRBelangerKMurkWBrackenMB. Antibiotic Exposure by 6 Months and Asthma and Allergy at 6 Years: Findings in a Cohort of 1,401 US Children. Am J Epidemiol (2011) 173(3):310–8. doi: 10.1093/aje/kwq400

  • CrossRef
  • Google Scholar

• 219

  MaiXMKullIWickmanMBergstromA. Antibiotic Use in Early Life and Development of Allergic Diseases: Respiratory Infection as the Explanation. Clin Exp Allergy (2010) 40(8):1230–7. doi: 10.1111/j.1365-2222.2010.03532.x

  • CrossRef
  • Google Scholar

• 220

  BoursiBMamtaniRHaynesKYangYX. The Effect of Past Antibiotic Exposure on Diabetes Risk. Eur J Endocrinol (2015) 172(6):639–48. doi: 10.1530/EJE-14-1163

  • CrossRef
  • Google Scholar

• 221

  MarkleJGFrankDNMortin-TothSRobertsonCEFeazelLMRolle-KampczykUet al. Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity. Science (2013) 339(6123):1084–8. doi: 10.1126/science.1233521

  • CrossRef
  • Google Scholar

• 222

  Vujkovic-CvijinISklarJJiangLNatarajanLKnightRBelkaidY. Host Variables Confound Gut Microbiota Studies of Human Disease. Nature (2020) 587(7834):448–54. doi: 10.1038/s41586-020-2881-9

  • CrossRef
  • Google Scholar

• 223

  NiJWuGDAlbenbergLTomovVT. Gut Microbiota and IBD: Causation or Correlation? Nat Rev Gastroenterol Hepatol (2017) 14(10):573–84. doi: 10.1038/nrgastro.2017.88

  • CrossRef
  • Google Scholar

• 224

  LichtmanJSMarcobalASonnenburgJLEliasJE. Host-Centric Proteomics of Stool: A Novel Strategy Focused on Intestinal Responses to the Gut Microbiota. Mol Cell Proteomics (2013) 12(11):3310–8. doi: 10.1074/mcp.M113.029967

  • CrossRef
  • Google Scholar

• 225

  MarcobalAKashyapPCNelsonTAAronovPADoniaMSSpormannAet al. A Metabolomic View of How the Human Gut Microbiota Impacts the Host Metabolome Using Humanized and Gnotobiotic Mice. ISME J (2013) 7(10):1933–43. doi: 10.1038/ismej.2013.89

  • CrossRef
  • Google Scholar

• 226

  SridharanGVChoiKKlemashevichCWuCPrabakaranDPanLBet al. Prediction and Quantification of Bioactive Microbiota Metabolites in the Mouse Gut. Nat Commun (2014) 5:5492. doi: 10.1038/ncomms6492

  • CrossRef
  • Google Scholar